Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1995 Jan;8(1):48–86. doi: 10.1128/cmr.8.1.48

Cholera.

J B Kaper 1, J G Morris Jr 1, M M Levine 1
PMCID: PMC172849  PMID: 7704895

Abstract

Despite more than a century of study, cholera still presents challenges and surprises to us. Throughout most of the 20th century, cholera was caused by Vibrio cholerae of the O1 serogroup and the disease was largely confined to Asia and Africa. However, the last decade of the 20th century has witnessed two major developments in the history of this disease. In 1991, a massive outbreak of cholera started in South America, the one continent previously untouched by cholera in this century. In 1992, an apparently new pandemic caused by a previously unknown serogroup of V. cholerae (O139) began in India and Bangladesh. The O139 epidemic has been occurring in populations assumed to be largely immune to V. cholerae O1 and has rapidly spread to many countries including the United States. In this review, we discuss all aspects of cholera, including the clinical microbiology, epidemiology, pathogenesis, and clinical features of the disease. Special attention will be paid to the extraordinary advances that have been made in recent years in unravelling the molecular pathogenesis of this infection and in the development of new generations of vaccines to prevent it.

Full Text

The Full Text of this article is available as a PDF (673.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott S. L., Janda J. M. Rapid detection of acute cholera in airline passengers by coagglutination assay. J Infect Dis. 1993 Sep;168(3):797–799. doi: 10.1093/infdis/168.3.797. [DOI] [PubMed] [Google Scholar]
  2. Albert M. J., Siddique A. K., Islam M. S., Faruque A. S., Ansaruzzaman M., Faruque S. M., Sack R. B. Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet. 1993 Mar 13;341(8846):704–704. doi: 10.1016/0140-6736(93)90481-u. [DOI] [PubMed] [Google Scholar]
  3. Alm R. A., Manning P. A. Biotype-specific probe for Vibrio cholerae serogroup O1. J Clin Microbiol. 1990 Apr;28(4):823–824. doi: 10.1128/jcm.28.4.823-824.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Alm R. A., Stroeher U. H., Manning P. A. Extracellular proteins of Vibrio cholerae: nucleotide sequence of the structural gene (hlyA) for the haemolysin of the haemolytic El Tor strain 017 and characterization of the hlyA mutation in the non-haemolytic classical strain 569B. Mol Microbiol. 1988 Jul;2(4):481–488. doi: 10.1111/j.1365-2958.1988.tb00054.x. [DOI] [PubMed] [Google Scholar]
  5. Almeida R. J., Hickman-Brenner F. W., Sowers E. G., Puhr N. D., Farmer J. J., 3rd, Wachsmuth I. K. Comparison of a latex agglutination assay and an enzyme-linked immunosorbent assay for detecting cholera toxin. J Clin Microbiol. 1990 Jan;28(1):128–130. doi: 10.1128/jcm.28.1.128-130.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Apter F. M., Michetti P., Winner L. S., 3rd, Mack J. A., Mekalanos J. J., Neutra M. R. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Infect Immun. 1993 Dec;61(12):5279–5285. doi: 10.1128/iai.61.12.5279-5285.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Attridge S. R., Dearlove C., Beyer L., van den Bosch L., Howles A., Hackett J., Morona R., LaBrooy J., Rowley D. Characterization and immunogenicity of EX880, a Salmonella typhi Ty21a-based clone which produces Vibrio cholerae O antigen. Infect Immun. 1991 Jul;59(7):2279–2284. doi: 10.1128/iai.59.7.2279-2284.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Attridge S. R., Rowley D. The role of the flagellum in the adherence of Vibrio cholerae. J Infect Dis. 1983 May;147(5):864–872. doi: 10.1093/infdis/147.5.864. [DOI] [PubMed] [Google Scholar]
  9. Attridge S. R., Rowley D. The specificity of Vibrio cholerae adherence and the significance of the slime agglutinin as a second mediator of in vitro attachment. J Infect Dis. 1983 May;147(5):873–881. doi: 10.1093/infdis/147.5.873. [DOI] [PubMed] [Google Scholar]
  10. Azurin J. C., Kobari K., Barua D., Alvero M., Gomez C. Z., Dizon J. J., Nakano E. I., Suplido R., Ledesma L. A long-term carrier of cholera: cholera Dolores. Bull World Health Organ. 1967;37(5):745–749. [PMC free article] [PubMed] [Google Scholar]
  11. Bagchi K., Echeverria P., Arthur J. D., Sethabutr O., Serichantalergs O., Hoge C. W. Epidemic of diarrhea caused by Vibrio cholerae non-O1 that produced heat-stable toxin among Khmers in a camp in Thailand. J Clin Microbiol. 1993 May;31(5):1315–1317. doi: 10.1128/jcm.31.5.1315-1317.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Baine W. B., Mazzotti M., Greco D., Izzo E., Zampieri A., Angioni G., Di Gioia M., Gangarosa E. J., Pocchiari F. Epidemiology of cholera in Italy in 1973. Lancet. 1974 Dec 7;2(7893):1370–1374. doi: 10.1016/s0140-6736(74)92233-8. [DOI] [PubMed] [Google Scholar]
  13. Barrett T. J., Blake P. A. Epidemiological usefulness of changes in hemolytic activity of Vibrio cholerae biotype El Tor during the seventh pandemic. J Clin Microbiol. 1981 Jan;13(1):126–129. doi: 10.1128/jcm.13.1.126-129.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Bartowsky E. J., Attridge S. R., Thomas C. J., Mayrhofer G., Manning P. A. Role of the P plasmid in attenuation of Vibrio cholerae O1. Infect Immun. 1990 Sep;58(9):3129–3134. doi: 10.1128/iai.58.9.3129-3134.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Baselski V., Briggs R., Parker C. Intestinal fluid accumulation induced by oral challenge with Vibrio cholerae or cholera toxin in infant mice. Infect Immun. 1977 Mar;15(3):704–712. doi: 10.1128/iai.15.3.704-712.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Baudry B., Fasano A., Ketley J., Kaper J. B. Cloning of a gene (zot) encoding a new toxin produced by Vibrio cholerae. Infect Immun. 1992 Feb;60(2):428–434. doi: 10.1128/iai.60.2.428-434.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Bear C. E., Li C. H., Kartner N., Bridges R. J., Jensen T. J., Ramjeesingh M., Riordan J. R. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell. 1992 Feb 21;68(4):809–818. doi: 10.1016/0092-8674(92)90155-6. [DOI] [PubMed] [Google Scholar]
  18. Benenson A. S., Saad A., Mosley W. H., Ahmed A. Serological studies in cholera. 3. Serum toxin neutralization--rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population of East Pakistan. Bull World Health Organ. 1968;38(2):287–295. [PMC free article] [PubMed] [Google Scholar]
  19. Bennett A. Cholera and prostaglandins. Nature. 1971 Jun 25;231(5304):536–536. doi: 10.1038/231536a0. [DOI] [PubMed] [Google Scholar]
  20. Berschneider H. M., Knowles M. R., Azizkhan R. G., Boucher R. C., Tobey N. A., Orlando R. C., Powell D. W. Altered intestinal chloride transport in cystic fibrosis. FASEB J. 1988 Jul;2(10):2625–2629. doi: 10.1096/fasebj.2.10.2838365. [DOI] [PubMed] [Google Scholar]
  21. Beubler E., Kollar G., Saria A., Bukhave K., Rask-Madsen J. Involvement of 5-hydroxytryptamine, prostaglandin E2, and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo. Gastroenterology. 1989 Feb;96(2 Pt 1):368–376. doi: 10.1016/0016-5085(89)91560-6. [DOI] [PubMed] [Google Scholar]
  22. Bhattacharya M. K., Bhattacharya S. K., Garg S., Saha P. K., Dutta D., Nair G. B., Deb B. C., Das K. P. Outbreak of Vibrio cholerae non-O1 in India and Bangladesh. Lancet. 1993 May 22;341(8856):1346–1347. doi: 10.1016/0140-6736(93)90855-b. [DOI] [PubMed] [Google Scholar]
  23. Bhattacharya S. K., Bhattacharya M. K., Nair G. B., Dutta D., Deb A., Ramamurthy T., Garg S., Saha P. K., Dutta P., Moitra A. Clinical profile of acute diarrhoea cases infected with the new epidemic strain of Vibrio cholerae O139: designation of the disease as cholera. J Infect. 1993 Jul;27(1):11–15. doi: 10.1016/0163-4453(93)93488-p. [DOI] [PubMed] [Google Scholar]
  24. Black R. E. The prophylaxis and therapy of secretory diarrhea. Med Clin North Am. 1982 May;66(3):611–621. doi: 10.1016/s0025-7125(16)31410-9. [DOI] [PubMed] [Google Scholar]
  25. Blake P. A., Allegra D. T., Snyder J. D., Barrett T. J., McFarland L., Caraway C. T., Feeley J. C., Craig J. P., Lee J. V., Puhr N. D. Cholera--a possible endemic focus in the United States. N Engl J Med. 1980 Feb 7;302(6):305–309. doi: 10.1056/NEJM198002073020601. [DOI] [PubMed] [Google Scholar]
  26. Bornside G. H. Jaime Ferran and preventive inoculation against cholera. Bull Hist Med. 1981 Winter;55(4):516–532. [PubMed] [Google Scholar]
  27. Brayton P. R., Tamplin M. L., Huq A., Colwell R. R. Enumeration of Vibrio cholerae O1 in Bangladesh waters by fluorescent-antibody direct viable count. Appl Environ Microbiol. 1987 Dec;53(12):2862–2865. doi: 10.1128/aem.53.12.2862-2865.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Brenner D. J., Davis B. R., Kudoh Y., Ohashi M., Sakazaki R., Shimada T., Smith H. L., Jr Serological comparison of two collections of Vibrio cholerae non O1. J Clin Microbiol. 1982 Aug;16(2):319–323. doi: 10.1128/jcm.16.2.319-323.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Bromander A., Holmgren J., Lycke N. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J Immunol. 1991 May 1;146(9):2908–2914. [PubMed] [Google Scholar]
  30. Butterton J. R., Stoebner J. A., Payne S. M., Calderwood S. B. Cloning, sequencing, and transcriptional regulation of viuA, the gene encoding the ferric vibriobactin receptor of Vibrio cholerae. J Bacteriol. 1992 Jun;174(11):3729–3738. doi: 10.1128/jb.174.11.3729-3738.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Calderwood S. B., Mekalanos J. J. Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus. J Bacteriol. 1987 Oct;169(10):4759–4764. doi: 10.1128/jb.169.10.4759-4764.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Cash R. A., Music S. I., Libonati J. P., Snyder M. J., Wenzel R. P., Hornick R. B. Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum. J Infect Dis. 1974 Jan;129(1):45–52. doi: 10.1093/infdis/129.1.45. [DOI] [PubMed] [Google Scholar]
  33. Cassel D., Selinger Z. Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site. Proc Natl Acad Sci U S A. 1977 Aug;74(8):3307–3311. doi: 10.1073/pnas.74.8.3307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Cassuto J., Fahrenkrug J., Jodal M., Tuttle R., Lundgren O. Release of vasoactive intestinal polypeptide from the cat small intestine exposed to cholera toxin. Gut. 1981 Nov;22(11):958–963. doi: 10.1136/gut.22.11.958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Cassuto J., Jodal M., Lundgren O. The effect of nicotinic and muscarinic receptor blockade on cholera toxin induced intestinal secretion in rats and cats. Acta Physiol Scand. 1982 Apr;114(4):573–577. doi: 10.1111/j.1748-1716.1982.tb07026.x. [DOI] [PubMed] [Google Scholar]
  36. Cassuto J., Jodal M., Tuttle R., Lundgren O. On the role of intramural nerves in the pathogenesis of cholera toxin-induced intestinal secretion. Scand J Gastroenterol. 1981 Apr;16(3):377–384. doi: 10.3109/00365528109181984. [DOI] [PubMed] [Google Scholar]
  37. Cassuto J., Siewert A., Jodal M., Lundgren O. The involvement of intramural nerves in cholera toxin induced intestinal secretion. Acta Physiol Scand. 1983 Feb;117(2):195–202. doi: 10.1111/j.1748-1716.1983.tb07197.x. [DOI] [PubMed] [Google Scholar]
  38. Chaicumpa W., Atthasisiha N. Study of intestinal immunity against V. cholerae: role of antibody to V. cholerae haemagglutinin in intestinal immunity. Southeast Asian J Trop Med Public Health. 1977 Mar;8(1):13–18. [PubMed] [Google Scholar]
  39. Chaicumpa W., Boonthum A., Kalumbaheti T., Tapchaisri P. Cell-bound haemagglutinin (CHA) of V. cholerae 01 as protective antigen. Southeast Asian J Trop Med Public Health. 1984 Sep;15(3):407–413. [PubMed] [Google Scholar]
  40. Chattopadhyay D. J., Sarkar B. L., Ansari M. Q., Chakrabarti B. K., Roy M. K., Ghosh A. N., Pal S. C. New phage typing scheme for Vibrio cholerae O1 biotype El Tor strains. J Clin Microbiol. 1993 Jun;31(6):1579–1585. doi: 10.1128/jcm.31.6.1579-1585.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Chitnis D. S., Sharma K. D., Kamat R. S. Role of somatic antigen of Vibrio cholerae in adhesion to intestinal mucosa. J Med Microbiol. 1982 Feb;15(1):53–61. doi: 10.1099/00222615-15-1-53. [DOI] [PubMed] [Google Scholar]
  42. Chongsa-nguan M., Chaicumpa W., Moolasart P., Kandhasingha P., Shimada T., Kurazono H., Takeda Y. Vibrio cholerae O139 Bengal in Bangkok. Lancet. 1993 Aug 14;342(8868):430–431. doi: 10.1016/0140-6736(93)92841-g. [DOI] [PubMed] [Google Scholar]
  43. Clemens J. D., Sack D. A., Harris J. R., Chakraborty J., Khan M. R., Huda S., Ahmed F., Gomes J., Rao M. R., Svennerholm A. M. ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy. J Infect Dis. 1989 Apr;159(4):770–773. doi: 10.1093/infdis/159.4.770. [DOI] [PubMed] [Google Scholar]
  44. Clemens J. D., Sack D. A., Harris J. R., Chakraborty J., Khan M. R., Stanton B. F., Kay B. A., Khan M. U., Yunus M., Atkinson W. Field trial of oral cholera vaccines in Bangladesh. Lancet. 1986 Jul 19;2(8499):124–127. doi: 10.1016/s0140-6736(86)91944-6. [DOI] [PubMed] [Google Scholar]
  45. Clemens J. D., Sack D. A., Harris J. R., Chakraborty J., Neogy P. K., Stanton B., Huda N., Khan M. U., Kay B. A., Khan M. R. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J Infect Dis. 1988 Aug;158(2):372–377. doi: 10.1093/infdis/158.2.372. [DOI] [PubMed] [Google Scholar]
  46. Clemens J. D., Sack D. A., Harris J. R., Khan M. R., Chakraborty J., Chowdhury S., Rao M. R., van Loon F. P., Stanton B. F., Yunus M. Breast feeding and the risk of severe cholera in rural Bangladeshi children. Am J Epidemiol. 1990 Mar;131(3):400–411. doi: 10.1093/oxfordjournals.aje.a115515. [DOI] [PubMed] [Google Scholar]
  47. Clemens J. D., van Loon F., Sack D. A., Rao M. R., Ahmed F., ChakrabortY J., Kay B. A., Khan M. R., Yunus M. D., Harris J. R. Biotype as determinant of natural immunising effect of cholera. Lancet. 1991 Apr 13;337(8746):883–884. doi: 10.1016/0140-6736(91)90207-6. [DOI] [PubMed] [Google Scholar]
  48. Clements J. D., El-Morshidy S. Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas. Infect Immun. 1984 Nov;46(2):564–569. doi: 10.1128/iai.46.2.564-569.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Clements M. L., Levine M. M., Young C. R., Black R. E., Lim Y. L., Robins-Browne R. M., Craig J. P. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. J Infect Dis. 1982 Apr;145(4):465–473. doi: 10.1093/infdis/145.4.465. [DOI] [PubMed] [Google Scholar]
  50. Cohen J., Schwartz T., Klasmer R., Pridan D., Ghalayini H., Davies A. M. Epidemiological aspects of cholera El Tor outbreak in a non-endemic area. Lancet. 1971 Jul 10;2(7715):86–89. doi: 10.1016/s0140-6736(71)92056-3. [DOI] [PubMed] [Google Scholar]
  51. Colwell R. R., Hasan J. A., Huq A., Loomis L., Siebeling R. J., Torres M., Galvez S., Islam S., Tamplin M. T., Bernstein D. Development and evaluation of a rapid, simple, sensitive, monoclonal antibody-based co-agglutination test for direct detection of Vibrio cholerae 01. FEMS Microbiol Lett. 1992 Oct 15;76(3):215–219. doi: 10.1016/0378-1097(92)90339-p. [DOI] [PubMed] [Google Scholar]
  52. Colwell R. R., Kaper J., Joseph S. W. Vibrio cholerae, Vibrio parahaemolyticus, and other vibrios: occurrence and distribution in Chesapeake Bay. Science. 1977 Oct 28;198(4315):394–396. [PubMed] [Google Scholar]
  53. Cook W. L., Wachsmuth K., Johnson S. R., Birkness K. A., Samadi A. R. Persistence of plasmids, cholera toxin genes, and prophage DNA in classical Vibrio cholerae O1. Infect Immun. 1984 Jul;45(1):222–226. doi: 10.1128/iai.45.1.222-226.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Cray W. C., Jr, Tokunaga E., Pierce N. F. Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1. Infect Immun. 1983 Aug;41(2):735–741. doi: 10.1128/iai.41.2.735-741.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Cryz S. J., Jr, Levine M. M., Kaper J. B., Fürer E., Althaus B. Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults. Vaccine. 1990 Dec;8(6):577–580. doi: 10.1016/0264-410x(90)90012-b. [DOI] [PubMed] [Google Scholar]
  56. Czerkinsky C., Russell M. W., Lycke N., Lindblad M., Holmgren J. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect Immun. 1989 Apr;57(4):1072–1077. doi: 10.1128/iai.57.4.1072-1077.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. DE S. N. Enterotoxicity of bacteria-free culture-filtrate of Vibrio cholerae. Nature. 1959 May 30;183(4674):1533–1534. doi: 10.1038/1831533a0. [DOI] [PubMed] [Google Scholar]
  58. DUTTA N. K., PANSE M. V., KULKARNI D. R. Role of cholera a toxin in experimental cholera. J Bacteriol. 1959 Oct;78:594–595. doi: 10.1128/jb.78.4.594-595.1959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. DePaola A., Capers G. M., Motes M. L., Olsvik O., Fields P. I., Wells J., Wachsmuth I. K., Cebula T. A., Koch W. H., Khambaty F. Isolation of Latin American epidemic strain of Vibrio cholerae O1 from US Gulf Coast. Lancet. 1992 Mar 7;339(8793):624–624. doi: 10.1016/0140-6736(92)90917-r. [DOI] [PubMed] [Google Scholar]
  60. Deb B. C., Sircar B. K., Sengupta P. G., De S. P., Mondal S. K., Gupta D. N., Saha N. C., Ghosh S., Mitra U., Pal S. C. Studies on interventions to prevent eltor cholera transmission in urban slums. Bull World Health Organ. 1986;64(1):127–131. [PMC free article] [PubMed] [Google Scholar]
  61. Dertzbaugh M. T., Peterson D. L., Macrina F. L. Cholera toxin B-subunit gene fusion: structural and functional analysis of the chimeric protein. Infect Immun. 1990 Jan;58(1):70–79. doi: 10.1128/iai.58.1.70-79.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Desmarchelier P. M., Momen H., Salles C. A. A zymovar analysis of Vibrio cholerae isolated in Australia. Trans R Soc Trop Med Hyg. 1988;82(6):914–917. doi: 10.1016/0035-9203(88)90041-7. [DOI] [PubMed] [Google Scholar]
  63. Desmarchelier P. M., Senn C. R. A molecular epidemiological study of Vibrio cholerae in Australia. Med J Aust. 1989 Jun 5;150(11):631–634. doi: 10.5694/j.1326-5377.1989.tb136726.x. [DOI] [PubMed] [Google Scholar]
  64. DiRita V. J. Co-ordinate expression of virulence genes by ToxR in Vibrio cholerae. Mol Microbiol. 1992 Feb;6(4):451–458. doi: 10.1111/j.1365-2958.1992.tb01489.x. [DOI] [PubMed] [Google Scholar]
  65. DiRita V. J., Mekalanos J. J. Periplasmic interaction between two membrane regulatory proteins, ToxR and ToxS, results in signal transduction and transcriptional activation. Cell. 1991 Jan 11;64(1):29–37. doi: 10.1016/0092-8674(91)90206-e. [DOI] [PubMed] [Google Scholar]
  66. DiRita V. J., Parsot C., Jander G., Mekalanos J. J. Regulatory cascade controls virulence in Vibrio cholerae. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5403–5407. doi: 10.1073/pnas.88.12.5403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Diamond J. M. Twenty-first Bowditch lecture. The epithelial junction: bridge, gate, and fence. Physiologist. 1977 Feb;20(1):10–18. [PubMed] [Google Scholar]
  68. Domínguez P., Velasco G., Barros F., Lazo P. S. Intestinal brush border membranes contain regulatory subunits of adenylyl cyclase. Proc Natl Acad Sci U S A. 1987 Oct;84(20):6965–6969. doi: 10.1073/pnas.84.20.6965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Donta S. T., Beristain S., Tomicic T. K. Inhibition of heat-labile cholera and Escherichia coli enterotoxins by brefeldin A. Infect Immun. 1993 Aug;61(8):3282–3286. doi: 10.1128/iai.61.8.3282-3286.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Donta S. T. Differentiation between the steroidogenic effects of cholera enterotoxin and adrenocorticotropin through use of a mutant adrenal cell line. J Infect Dis. 1974 Jun;129(6):728–731. doi: 10.1093/infdis/129.6.728. [DOI] [PubMed] [Google Scholar]
  71. Dubey R. S., Lindblad M., Holmgren J. Purification of El Tor cholera enterotoxins and comparisons with classical toxin. J Gen Microbiol. 1990 Sep;136(9):1839–1847. doi: 10.1099/00221287-136-9-1839. [DOI] [PubMed] [Google Scholar]
  72. Ehara M., Ishibashi M., Ichinose Y., Iwanaga M., Shimotori S., Naito T. Purification and partial characterization of fimbriae of Vibrio cholerae O1. Vaccine. 1987 Dec;5(4):283–288. doi: 10.1016/0264-410x(87)90153-8. [DOI] [PubMed] [Google Scholar]
  73. Eubanks E. R., Guentzel M. N., Berry L. J. Evaluation of surface components of Vibrio cholerae as protective immunogens. Infect Immun. 1977 Feb;15(2):533–538. doi: 10.1128/iai.15.2.533-538.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. FINKELSTEIN R. A., LABREC E. H. Rapid identification of cholera vibrios with fluorescent antibody. J Bacteriol. 1959 Dec;78:886–891. doi: 10.1128/jb.78.6.886-891.1959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. FOLLETT E. A., GORDON J. AN ELECTRON MICROSCOPE STUDY OF VIBRIO FLAGELLA. J Gen Microbiol. 1963 Aug;32:235–239. doi: 10.1099/00221287-32-2-235. [DOI] [PubMed] [Google Scholar]
  76. Faruque S. M., Abdul Alim A. R., Rahman M. M., Siddique A. K., Sack R. B., Albert M. J. Clonal relationships among classical Vibrio cholerae O1 strains isolated between 1961 and 1992 in Bangladesh. J Clin Microbiol. 1993 Sep;31(9):2513–2516. doi: 10.1128/jcm.31.9.2513-2516.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Fasano A., Baudry B., Pumplin D. W., Wasserman S. S., Tall B. D., Ketley J. M., Kaper J. B. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5242–5246. doi: 10.1073/pnas.88.12.5242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Felsenfeld O. Notes on food, beverages and fomites contaminated with Vibrio cholerae. Bull World Health Organ. 1965;33(5):725–734. [PMC free article] [PubMed] [Google Scholar]
  79. Field M: Intestinal secretion: effect of cyclic AMP and its role in cholera. N Engl J Med. 1971 May 20;284(20):1137–1144. doi: 10.1056/NEJM197105202842008. [DOI] [PubMed] [Google Scholar]
  80. Field M., Fromm D., al-Awqati Q., Greenough W. B., 3rd Effect of cholera enterotoxin on ion transport across isolated ileal mucosa. J Clin Invest. 1972 Apr;51(4):796–804. doi: 10.1172/JCI106874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Field M., Rao M. C., Chang E. B. Intestinal electrolyte transport and diarrheal disease (2) N Engl J Med. 1989 Sep 28;321(13):879–883. doi: 10.1056/NEJM198909283211307. [DOI] [PubMed] [Google Scholar]
  82. Fields P. I., Popovic T., Wachsmuth K., Olsvik O. Use of polymerase chain reaction for detection of toxigenic Vibrio cholerae O1 strains from the Latin American cholera epidemic. J Clin Microbiol. 1992 Aug;30(8):2118–2121. doi: 10.1128/jcm.30.8.2118-2121.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Finch M. J., Morris J. G., Jr, Kaviti J., Kagwanja W., Levine M. M. Epidemiology of antimicrobial resistant cholera in Kenya and East Africa. Am J Trop Med Hyg. 1988 Nov;39(5):484–490. doi: 10.4269/ajtmh.1988.39.484. [DOI] [PubMed] [Google Scholar]
  84. Finelli L., Swerdlow D., Mertz K., Ragazzoni H., Spitalny K. Outbreak of cholera associated with crab brought from an area with epidemic disease. J Infect Dis. 1992 Dec;166(6):1433–1435. doi: 10.1093/infdis/166.6.1433. [DOI] [PubMed] [Google Scholar]
  85. Finkelstein R. A., Boesman-Finkelstein M., Chang Y., Häse C. C. Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment. Infect Immun. 1992 Feb;60(2):472–478. doi: 10.1128/iai.60.2.472-478.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Finkelstein R. A., Boesman-Finkelstein M., Holt P. Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F.M. Burnet revisited. Proc Natl Acad Sci U S A. 1983 Feb;80(4):1092–1095. doi: 10.1073/pnas.80.4.1092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Finkelstein R. A., LoSpalluto J. J. Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid. J Exp Med. 1969 Jul 1;130(1):185–202. doi: 10.1084/jem.130.1.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Finn T. M., Reiser J., Germanier R., Cryz S. J., Jr Cell-associated hemagglutinin-deficient mutant of Vibrio cholerae. Infect Immun. 1987 Apr;55(4):942–946. doi: 10.1128/iai.55.4.942-946.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Forrest B. D., LaBrooy J. T., Attridge S. R., Boehm G., Beyer L., Morona R., Shearman D. J., Rowley D. Immunogenicity of a candidate live oral typhoid/cholera hybrid vaccine in humans. J Infect Dis. 1989 Jan;159(1):145–146. doi: 10.1093/infdis/159.1.145. [DOI] [PubMed] [Google Scholar]
  90. Francis M. L., Ryan J., Jobling M. G., Holmes R. K., Moss J., Mond J. J. Cyclic AMP-independent effects of cholera toxin on B cell activation. II. Binding of ganglioside GM1 induces B cell activation. J Immunol. 1992 Apr 1;148(7):1999–2005. [PubMed] [Google Scholar]
  91. Franzon V. L., Barker A., Manning P. A. Nucleotide sequence encoding the mannose-fucose-resistant hemagglutinin of Vibrio cholerae O1 and construction of a mutant. Infect Immun. 1993 Jul;61(7):3032–3037. doi: 10.1128/iai.61.7.3032-3037.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Franzon V. L., Manning P. A. Molecular cloning and expression in Escherichia coli K-12 of the gene for a hemagglutinin from Vibrio cholerae. Infect Immun. 1986 Apr;52(1):279–284. doi: 10.1128/iai.52.1.279-284.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Freer J. H., Birkbeck T. H. Possible conformation of delta-lysin, a membrane-damaging peptide of Staphylococcus aureus. J Theor Biol. 1982 Feb 7;94(3):535–540. doi: 10.1016/0022-5193(82)90299-5. [DOI] [PubMed] [Google Scholar]
  94. Freter R., Allweiss B., O'Brien P. C., Halstead S. A., Macsai M. S. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vitro studies. Infect Immun. 1981 Oct;34(1):241–249. doi: 10.1128/iai.34.1.241-249.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Freter R., Jones G. W. Adhesive properties of Vibrio cholerae: nature of the interaction with intact mucosal surfaces. Infect Immun. 1976 Jul;14(1):246–256. doi: 10.1128/iai.14.1.246-256.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Freter R., O'Brien P. C., Macsai M. S. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies. Infect Immun. 1981 Oct;34(1):234–240. doi: 10.1128/iai.34.1.234-240.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Freter R., O'Brien P. C. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: fitness and virulence of nonchemotactic Vibrio cholerae mutants in infant mice. Infect Immun. 1981 Oct;34(1):222–233. doi: 10.1128/iai.34.1.222-233.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Fuerst J. A., Perry J. W. Demonstration of lipopolysaccharide on sheathed flagella of Vibrio cholerae O:1 by protein A-gold immunoelectron microscopy. J Bacteriol. 1988 Apr;170(4):1488–1494. doi: 10.1128/jb.170.4.1488-1494.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Galen J. E., Ketley J. M., Fasano A., Richardson S. H., Wasserman S. S., Kaper J. B. Role of Vibrio cholerae neuraminidase in the function of cholera toxin. Infect Immun. 1992 Feb;60(2):406–415. doi: 10.1128/iai.60.2.406-415.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Gennaro M. L., Greenaway P. J., Broadbent D. A. The expression of biologically active cholera toxin in Escherichia coli. Nucleic Acids Res. 1982 Aug 25;10(16):4883–4890. doi: 10.1093/nar/10.16.4883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Gill D. M., King C. A. The mechanism of action of cholera toxin in pigeon erythrocyte lysates. J Biol Chem. 1975 Aug 25;250(16):6424–6432. [PubMed] [Google Scholar]
  102. Gill D. M., Rappaport R. S. Origin of the enzymatically active A1 fragment of cholera toxin. J Infect Dis. 1979 Jun;139(6):674–680. doi: 10.1093/infdis/139.6.674. [DOI] [PubMed] [Google Scholar]
  103. Glass R. I., Becker S., Huq M. I., Stoll B. J., Khan M. U., Merson M. H., Lee J. V., Black R. E. Endemic cholera in rural Bangladesh, 1966-1980. Am J Epidemiol. 1982 Dec;116(6):959–970. doi: 10.1093/oxfordjournals.aje.a113498. [DOI] [PubMed] [Google Scholar]
  104. Glass R. I., Claeson M., Blake P. A., Waldman R. J., Pierce N. F. Cholera in Africa: lessons on transmission and control for Latin America. Lancet. 1991 Sep 28;338(8770):791–795. doi: 10.1016/0140-6736(91)90673-d. [DOI] [PubMed] [Google Scholar]
  105. Glass R. I., Holmgren J., Haley C. E., Khan M. R., Svennerholm A. M., Stoll B. J., Belayet Hossain K. M., Black R. E., Yunus M., Barua D. Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. Am J Epidemiol. 1985 Jun;121(6):791–796. doi: 10.1093/oxfordjournals.aje.a114050. [DOI] [PubMed] [Google Scholar]
  106. Glass R. I., Huq I., Alim A. R., Yunus M. Emergence of multiply antibiotic-resistant Vibrio cholerae in Bangladesh. J Infect Dis. 1980 Dec;142(6):939–942. doi: 10.1093/infdis/142.6.939. [DOI] [PubMed] [Google Scholar]
  107. Glass R. I., Svennerholm A. M., Khan M. R., Huda S., Huq M. I., Holmgren J. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J Infect Dis. 1985 Feb;151(2):236–242. doi: 10.1093/infdis/151.2.236. [DOI] [PubMed] [Google Scholar]
  108. Glass R. I., Svennerholm A. M., Stoll B. J., Khan M. R., Hossain K. M., Huq M. I., Holmgren J. Protection against cholera in breast-fed children by antibodies in breast milk. N Engl J Med. 1983 Jun 9;308(23):1389–1392. doi: 10.1056/NEJM198306093082304. [DOI] [PubMed] [Google Scholar]
  109. Goldberg I., Mekalanos J. J. Effect of a recA mutation on cholera toxin gene amplification and deletion events. J Bacteriol. 1986 Mar;165(3):723–731. doi: 10.1128/jb.165.3.723-731.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Goldberg M. B., Boyko S. A., Calderwood S. B. Positive transcriptional regulation of an iron-regulated virulence gene in Vibrio cholerae. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1125–1129. doi: 10.1073/pnas.88.4.1125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Goldberg M. B., Boyko S. A., Calderwood S. B. Transcriptional regulation by iron of a Vibrio cholerae virulence gene and homology of the gene to the Escherichia coli fur system. J Bacteriol. 1990 Dec;172(12):6863–6870. doi: 10.1128/jb.172.12.6863-6870.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Goldberg M. B., DiRita V. J., Calderwood S. B. Identification of an iron-regulated virulence determinant in Vibrio cholerae, using TnphoA mutagenesis. Infect Immun. 1990 Jan;58(1):55–60. doi: 10.1128/iai.58.1.55-60.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Goldberg S., Murphy J. R. Molecular epidemiological studies of United States Gulf Coast Vibrio cholerae strains: integration site of mutator vibriophage VcA-3. Infect Immun. 1983 Oct;42(1):224–230. doi: 10.1128/iai.42.1.224-230.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Goodgame R. W., Greenough W. B. Cholera in Africa: a message for the West. Ann Intern Med. 1975 Jan;82(1):101–106. doi: 10.7326/0003-4819-82-1-101. [DOI] [PubMed] [Google Scholar]
  115. Griffiths G. L., Sigel S. P., Payne S. M., Neilands J. B. Vibriobactin, a siderophore from Vibrio cholerae. J Biol Chem. 1984 Jan 10;259(1):383–385. [PubMed] [Google Scholar]
  116. Griffiths S. L., Finkelstein R. A., Critchley D. R. Characterization of the receptor for cholera toxin and Escherichia coli heat-labile toxin in rabbit intestinal brush borders. Biochem J. 1986 Sep 1;238(2):313–322. doi: 10.1042/bj2380313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Guentzel M. N., Berry L. J. Motility as a virulence factor for Vibrio cholerae. Infect Immun. 1975 May;11(5):890–897. doi: 10.1128/iai.11.5.890-897.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Guerrant R. L., Brunton L. L., Schnaitman T. C., Rebhun L. I., Gilman A. G. Cyclic adenosine monophosphate and alteration of Chinese hamster ovary cell morphology: a rapid, sensitive in vitro assay for the enterotoxins of Vibrio cholerae and Escherichia coli. Infect Immun. 1974 Aug;10(2):320–327. doi: 10.1128/iai.10.2.320-327.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Gustafsson B., Holme T. Rapid detection of Vibrio cholerae O:1 by motility inhibition and immunofluorescence with monoclonal antibodies. Eur J Clin Microbiol. 1985 Jun;4(3):291–294. doi: 10.1007/BF02013655. [DOI] [PubMed] [Google Scholar]
  120. Hall R. H., Khambaty F. M., Kothary M., Keasler S. P. Non-O1 Vibrio cholerae. Lancet. 1993 Aug 14;342(8868):430–430. doi: 10.1016/0140-6736(93)92839-l. [DOI] [PubMed] [Google Scholar]
  121. Hall R. H., Losonsky G., Silveira A. P., Taylor R. K., Mekalanos J. J., Witham N. D., Levine M. M. Immunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera. Infect Immun. 1991 Jul;59(7):2508–2512. doi: 10.1128/iai.59.7.2508-2512.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Hall R. H., Vial P. A., Kaper J. B., Mekalanos J. J., Levine M. M. Morphological studies on fimbriae expressed by Vibrio cholerae 01. Microb Pathog. 1988 Apr;4(4):257–265. doi: 10.1016/0882-4010(88)90086-1. [DOI] [PubMed] [Google Scholar]
  123. Hanne L. F., Finkelstein R. A. Characterization and distribution of the hemagglutinins produced by Vibrio cholerae. Infect Immun. 1982 Apr;36(1):209–214. doi: 10.1128/iai.36.1.209-214.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Hasan J. A., Huq A., Tamplin M. L., Siebeling R. J., Colwell R. R. A novel kit for rapid detection of Vibrio cholerae O1. J Clin Microbiol. 1994 Jan;32(1):249–252. doi: 10.1128/jcm.32.1.249-252.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Hecht G., Pothoulakis C., LaMont J. T., Madara J. L. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest. 1988 Nov;82(5):1516–1524. doi: 10.1172/JCI113760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Hedges R. W., Vialard J. L., Pearson N. J., O'Grady F. R plasmids from Asian strains of Vibrio cholerae. Antimicrob Agents Chemother. 1977 Apr;11(4):585–588. doi: 10.1128/aac.11.4.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Henderson D. P., Payne S. M. Cloning and characterization of the Vibrio cholerae genes encoding the utilization of iron from haemin and haemoglobin. Mol Microbiol. 1993 Feb;7(3):461–469. doi: 10.1111/j.1365-2958.1993.tb01137.x. [DOI] [PubMed] [Google Scholar]
  128. Hepler J. R., Gilman A. G. G proteins. Trends Biochem Sci. 1992 Oct;17(10):383–387. doi: 10.1016/0968-0004(92)90005-t. [DOI] [PubMed] [Google Scholar]
  129. Herrington D. A., Hall R. H., Losonsky G., Mekalanos J. J., Taylor R. K., Levine M. M. Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans. J Exp Med. 1988 Oct 1;168(4):1487–1492. doi: 10.1084/jem.168.4.1487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Higgins D. E., Nazareno E., DiRita V. J. The virulence gene activator ToxT from Vibrio cholerae is a member of the AraC family of transcriptional activators. J Bacteriol. 1992 Nov;174(21):6974–6980. doi: 10.1128/jb.174.21.6974-6980.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Hoge C. W., Sethabutr O., Bodhidatta L., Echeverria P., Robertson D. C., Morris J. G., Jr Use of a synthetic oligonucleotide probe to detect strains of non-serovar O1 Vibrio cholerae carrying the gene for heat-stable enterotoxin (NAG-ST). J Clin Microbiol. 1990 Jun;28(6):1473–1476. doi: 10.1128/jcm.28.6.1473-1476.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Holmberg S. D., Harris J. R., Kay D. E., Hargrett N. T., Parker R. D., Kansou N., Rao N. U., Blake P. A. Foodborne transmission of cholera in Micronesian households. Lancet. 1984 Feb 11;1(8372):325–328. doi: 10.1016/s0140-6736(84)90370-2. [DOI] [PubMed] [Google Scholar]
  133. Holmgren J., Lycke N., Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine. 1993 Sep;11(12):1179–1184. doi: 10.1016/0264-410x(93)90039-z. [DOI] [PubMed] [Google Scholar]
  134. Holmgren J., Lönnroth I., Månsson J., Svennerholm L. Interaction of cholera toxin and membrane GM1 ganglioside of small intestine. Proc Natl Acad Sci U S A. 1975 Jul;72(7):2520–2524. doi: 10.1073/pnas.72.7.2520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Holmgren J., Svennerholm A. M. Mechanisms of disease and immunity in cholera: a review. J Infect Dis. 1977 Aug;136 (Suppl):S105–S112. doi: 10.1093/infdis/136.supplement.s105. [DOI] [PubMed] [Google Scholar]
  136. Honda T., Finkelstein R. A. Purification and characterization of a hemolysin produced by Vibrio cholerae biotype El Tor: another toxic substance produced by cholera vibrios. Infect Immun. 1979 Dec;26(3):1020–1027. doi: 10.1128/iai.26.3.1020-1027.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Honda T., Finkelstein R. A. Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin. Proc Natl Acad Sci U S A. 1979 Apr;76(4):2052–2056. doi: 10.1073/pnas.76.4.2052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Honda T., Nishibuchi M., Miwatani T., Kaper J. B. Demonstration of a plasmid-borne gene encoding a thermostable direct hemolysin in Vibrio cholerae non-O1 strains. Appl Environ Microbiol. 1986 Nov;52(5):1218–1220. doi: 10.1128/aem.52.5.1218-1220.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Hood M. A., Guckert J. B., White D. C., Deck F. Effect of nutrient deprivation on lipid, carbohydrate, DNA, RNA, and protein levels in Vibrio cholerae. Appl Environ Microbiol. 1986 Oct;52(4):788–793. doi: 10.1128/aem.52.4.788-793.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Hranitzky K. W., Mulholland A., Larson A. D., Eubanks E. R., Hart L. T. Characterization of a flagellar sheath protein of Vibrio cholerae. Infect Immun. 1980 Feb;27(2):597–603. doi: 10.1128/iai.27.2.597-603.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Hughes J. M., Boyce J. M., Levine R. J., Khan M., Aziz K. M., Huq M. I., Curlin G. T. Epidemiology of eltor cholera in rural Bangladesh: importance of surface water in transmission. Bull World Health Organ. 1982;60(3):395–404. [PMC free article] [PubMed] [Google Scholar]
  142. Hughes J. M., Hollis D. G., Gangarosa E. J., Weaver R. E. Non-cholera vibrio infections in the United States. Clinical, epidemiologic, and laboratory features. Ann Intern Med. 1978 May;88(5):602–606. doi: 10.7326/0003-4819-88-5-602. [DOI] [PubMed] [Google Scholar]
  143. Huq A., Small E. B., West P. A., Huq M. I., Rahman R., Colwell R. R. Ecological relationships between Vibrio cholerae and planktonic crustacean copepods. Appl Environ Microbiol. 1983 Jan;45(1):275–283. doi: 10.1128/aem.45.1.275-283.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Häse C. C., Finkelstein R. A. Cloning and nucleotide sequence of the Vibrio cholerae hemagglutinin/protease (HA/protease) gene and construction of an HA/protease-negative strain. J Bacteriol. 1991 Jun;173(11):3311–3317. doi: 10.1128/jb.173.11.3311-3317.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Ichinose Y., Yamamoto K., Nakasone N., Tanabe M. J., Takeda T., Miwatani T., Iwanaga M. Enterotoxicity of El Tor-like hemolysin of non-O1 Vibrio cholerae. Infect Immun. 1987 May;55(5):1090–1093. doi: 10.1128/iai.55.5.1090-1093.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Iredell J. R., Manning P. A. Biotype-specific tcpA genes in Vibrio cholerae. FEMS Microbiol Lett. 1994 Aug 1;121(1):47–54. doi: 10.1111/j.1574-6968.1994.tb07074.x. [DOI] [PubMed] [Google Scholar]
  147. Islam M. S., Hasan M. K., Miah M. A., Qadri F., Yunus M., Sack R. B., Albert M. J. Isolation of Vibrio cholerae O139 Bengal from water in Bangladesh. Lancet. 1993 Aug 14;342(8868):430–430. doi: 10.1016/0140-6736(93)92840-p. [DOI] [PubMed] [Google Scholar]
  148. Ito T., Hiramatsu K., Ohshita Y., Yokota T. Mutations in the rfbT gene are responsible for the Ogawa to inaba serotype conversion in Vibrio cholerae O1. Microbiol Immunol. 1993;37(4):281–288. doi: 10.1111/j.1348-0421.1993.tb03211.x. [DOI] [PubMed] [Google Scholar]
  149. Jacob A., Sinha V. B., Sahib M. K., Srivastava R., Kaper J. B., Srivastava B. S. Identification of a 33 kDa antigen associated with an adhesive and colonizing strain of Vibrio cholerae El Tor and its role in protection. Vaccine. 1993;11(3):376–382. doi: 10.1016/0264-410x(93)90203-a. [DOI] [PubMed] [Google Scholar]
  150. Jalajakumari M. B., Manning P. A. Nucleotide sequence of the gene, ompW, encoding a 22kDa immunogenic outer membrane protein of Vibrio cholerae. Nucleic Acids Res. 1990 Apr 25;18(8):2180–2180. doi: 10.1093/nar/18.8.2180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Janicot M., Fouque F., Desbuquois B. Activation of rat liver adenylate cyclase by cholera toxin requires toxin internalization and processing in endosomes. J Biol Chem. 1991 Jul 15;266(20):12858–12865. [PubMed] [Google Scholar]
  152. Jesudason M. V., Cherian A. M., John T. J. Blood stream invasion by Vibrio cholerae O139. Lancet. 1993 Aug 14;342(8868):431–431. doi: 10.1016/0140-6736(93)92842-h. [DOI] [PubMed] [Google Scholar]
  153. Jesudason M. V., Thangavelu C. P., Lalitha M. K. Rapid screening of fecal samples for Vibrio cholerae by a coagglutination technique. J Clin Microbiol. 1984 May;19(5):712–713. doi: 10.1128/jcm.19.5.712-713.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Johnson J. A., Morris J. G., Jr, Kaper J. B. Gene encoding zonula occludens toxin (zot) does not occur independently from cholera enterotoxin genes (ctx) in Vibrio cholerae. J Clin Microbiol. 1993 Mar;31(3):732–733. doi: 10.1128/jcm.31.3.732-733.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Johnson J. A., Panigrahi P., Morris J. G., Jr Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice. Infect Immun. 1992 Mar;60(3):864–869. doi: 10.1128/iai.60.3.864-869.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Johnson J. A., Salles C. A., Panigrahi P., Albert M. J., Wright A. C., Johnson R. J., Morris J. G., Jr Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect Immun. 1994 May;62(5):2108–2110. doi: 10.1128/iai.62.5.2108-2110.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Johnston J. M., Martin D. L., Perdue J., McFarland L. M., Caraway C. T., Lippy E. C., Blake P. A. Cholera on a Gulf Coast oil rig. N Engl J Med. 1983 Sep 1;309(9):523–526. doi: 10.1056/NEJM198309013090903. [DOI] [PubMed] [Google Scholar]
  158. Jones G. W., Freter R. Adhesive properties of Vibrio cholerae: nature of the interaction with isolated rabbit brush border membranes and human erythrocytes. Infect Immun. 1976 Jul;14(1):240–245. doi: 10.1128/iai.14.1.240-245.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Jonson G., Holmgren J., Svennerholm A. M. Analysis of expression of toxin-coregulated pili in classical and El Tor Vibrio cholerae O1 in vitro and in vivo. Infect Immun. 1992 Oct;60(10):4278–4284. doi: 10.1128/iai.60.10.4278-4284.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Jonson G., Holmgren J., Svennerholm A. M. Epitope differences in toxin-coregulated pili produced by classical and El Tor Vibrio cholerae O1. Microb Pathog. 1991 Sep;11(3):179–188. doi: 10.1016/0882-4010(91)90048-f. [DOI] [PubMed] [Google Scholar]
  161. Jonson G., Holmgren J., Svennerholm A. M. Identification of a mannose-binding pilus on Vibrio cholerae El Tor. Microb Pathog. 1991 Dec;11(6):433–441. doi: 10.1016/0882-4010(91)90039-d. [DOI] [PubMed] [Google Scholar]
  162. Jonson G., Lebens M., Holmgren J. Cloning and sequencing of Vibrio cholerae mannose-sensitive haemagglutinin pilin gene: localization of mshA within a cluster of type 4 pilin genes. Mol Microbiol. 1994 Jul;13(1):109–118. doi: 10.1111/j.1365-2958.1994.tb00406.x. [DOI] [PubMed] [Google Scholar]
  163. Jonson G., Svennerholm A. M., Holmgren J. Vibrio cholerae expresses cell surface antigens during intestinal infection which are not expressed during in vitro culture. Infect Immun. 1989 Jun;57(6):1809–1815. doi: 10.1128/iai.57.6.1809-1815.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Kahn R. A., Gilman A. G. ADP-ribosylation of Gs promotes the dissociation of its alpha and beta subunits. J Biol Chem. 1984 May 25;259(10):6235–6240. [PubMed] [Google Scholar]
  165. Kaper J. B., Bradford H. B., Roberts N. C., Falkow S. Molecular epidemiology of Vibrio cholerae in the U.S. Gulf Coast. J Clin Microbiol. 1982 Jul;16(1):129–134. doi: 10.1128/jcm.16.1.129-134.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Kaper J. B., Levine M. M. Cloned cholera enterotoxin genes in study and prevention of cholera. Lancet. 1981 Nov 21;2(8256):1162–1163. doi: 10.1016/s0140-6736(81)90605-x. [DOI] [PubMed] [Google Scholar]
  167. Kaper J. B., Lockman H., Baldini M. M., Levine M. M. Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates. Nature. 1984 Apr 12;308(5960):655–658. doi: 10.1038/308655a0. [DOI] [PubMed] [Google Scholar]
  168. Kaper J. B., Moseley S. L., Falkow S. Molecular characterization of environmental and nontoxigenic strains of Vibrio cholerae. Infect Immun. 1981 May;32(2):661–667. doi: 10.1128/iai.32.2.661-667.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Kaper J. B., Nataro J. P., Roberts N. C., Siebeling R. J., Bradford H. B. Molecular epidemiology of non-O1 Vibrio cholerae and Vibrio mimicus in the U.S. Gulf Coast region. J Clin Microbiol. 1986 Mar;23(3):652–654. doi: 10.1128/jcm.23.3.652-654.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Kaper J., Lockman H., Colwell R. R., Joseph S. W. Ecology, serology, and enterotoxin production of Vibrio cholerae in Chesapeake Bay. Appl Environ Microbiol. 1979 Jan;37(1):91–103. doi: 10.1128/aem.37.1.91-103.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Kapral F. A., O'Brien A. D., Ruff P. D., Drugan W. J., Jr Inhibition of water absorption in the intestine by Staphylococcus aureus delta-toxin. Infect Immun. 1976 Jan;13(1):140–145. doi: 10.1128/iai.13.1.140-145.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Karasawa T., Mihara T., Kurazono H., Nair G. B., Garg S., Ramamurthy T., Takeda Y. Distribution of the zot (zonula occludens toxin) gene among strains of Vibrio cholerae 01 and non-01. FEMS Microbiol Lett. 1993 Jan 15;106(2):143–145. doi: 10.1111/j.1574-6968.1993.tb05950.x. [DOI] [PubMed] [Google Scholar]
  173. Kaufman M. R., Shaw C. E., Jones I. D., Taylor R. K. Biogenesis and regulation of the Vibrio cholerae toxin-coregulated pilus: analogies to other virulence factor secretory systems. Gene. 1993 Apr 15;126(1):43–49. doi: 10.1016/0378-1119(93)90588-t. [DOI] [PubMed] [Google Scholar]
  174. Keasler S. P., Hall R. H. Detecting and biotyping Vibrio cholerae O1 with multiplex polymerase chain reaction. Lancet. 1993 Jun 26;341(8861):1661–1661. doi: 10.1016/0140-6736(93)90792-f. [DOI] [PubMed] [Google Scholar]
  175. Kenne L., Lindberg B., Unger P., Gustafsson B., Holme T. Structural studies of the Vibrio cholerae O-antigen. Carbohydr Res. 1982 Mar 1;100:341–349. doi: 10.1016/s0008-6215(00)81047-2. [DOI] [PubMed] [Google Scholar]
  176. Ketley J. M., Michalski J., Galen J., Levine M. M., Kaper J. B. Construction of genetically marked Vibrio cholerae O1 vaccine strains. FEMS Microbiol Lett. 1993 Jul 15;111(1):15–21. doi: 10.1111/j.1574-6968.1993.tb06355.x. [DOI] [PubMed] [Google Scholar]
  177. Kimberg D. V., Field M., Johnson J., Henderson A., Gershon E. Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins. J Clin Invest. 1971 Jun;50(6):1218–1230. doi: 10.1172/JCI106599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. King C. A., Van Heyningen W. E. Deactivation of cholera toxin by a sialidase-resistant monosialosylganglioside. J Infect Dis. 1973 Jun;127(6):639–647. doi: 10.1093/infdis/127.6.639. [DOI] [PubMed] [Google Scholar]
  179. Klontz K. C., Tauxe R. V., Cook W. L., Riley W. H., Wachsmuth I. K. Cholera after the consumption of raw oysters. A case report. Ann Intern Med. 1987 Dec;107(6):846–848. doi: 10.7326/0003-4819-107-6-846. [DOI] [PubMed] [Google Scholar]
  180. Koblavi S., Grimont F., Grimont P. A. Clonal diversity of Vibrio cholerae O1 evidenced by rRNA gene restriction patterns. Res Microbiol. 1990 Jul-Aug;141(6):645–657. doi: 10.1016/0923-2508(90)90059-y. [DOI] [PubMed] [Google Scholar]
  181. Koch W. H., Payne W. L., Wentz B. A., Cebula T. A. Rapid polymerase chain reaction method for detection of Vibrio cholerae in foods. Appl Environ Microbiol. 1993 Feb;59(2):556–560. doi: 10.1128/aem.59.2.556-560.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Kolvin J. L., Roberts D. Studies on the growth of Vibrio cholerae biotype eltor and biotype classical in foods. J Hyg (Lond) 1982 Oct;89(2):243–252. doi: 10.1017/s0022172400070777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Koonin E. V. The second cholera toxin, Zot, and its plasmid-encoded and phage-encoded homologues constitute a group of putative ATPases with an altered purine NTP-binding motif. FEBS Lett. 1992 Nov 2;312(1):3–6. doi: 10.1016/0014-5793(92)81398-6. [DOI] [PubMed] [Google Scholar]
  184. Kotloff K. L., Wasserman S. S., O'Donnell S., Losonsky G. A., Cryz S. J., Levine M. M. Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial. Infect Immun. 1992 Oct;60(10):4430–4432. doi: 10.1128/iai.60.10.4430-4432.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Krause M., Roudier C., Fierer J., Harwood J., Guiney D. Molecular analysis of the virulence locus of the Salmonella dublin plasmid pSDL2. Mol Microbiol. 1991 Feb;5(2):307–316. doi: 10.1111/j.1365-2958.1991.tb02111.x. [DOI] [PubMed] [Google Scholar]
  186. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Cholera Working Group, International Centre for Diarrhoeal Diseases Research, Bangladesh. Lancet. 1993 Aug 14;342(8868):387–390. [PubMed] [Google Scholar]
  187. Lebens M., Johansson S., Osek J., Lindblad M., Holmgren J. Large-scale production of Vibrio cholerae toxin B subunit for use in oral vaccines. Biotechnology (N Y) 1993 Dec;11(13):1574–1578. doi: 10.1038/nbt1293-1574. [DOI] [PubMed] [Google Scholar]
  188. Lencer W. I., Delp C., Neutra M. R., Madara J. L. Mechanism of cholera toxin action on a polarized human intestinal epithelial cell line: role of vesicular traffic. J Cell Biol. 1992 Jun;117(6):1197–1209. doi: 10.1083/jcb.117.6.1197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Lencer W. I., de Almeida J. B., Moe S., Stow J. L., Ausiello D. A., Madara J. L. Entry of cholera toxin into polarized human intestinal epithelial cells. Identification of an early brefeldin A sensitive event required for A1-peptide generation. J Clin Invest. 1993 Dec;92(6):2941–2951. doi: 10.1172/JCI116917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Lesmana M., Subekti D., Tjaniadi P., Pazzaglia G. Modified CAMP test for biogrouping Vibrio cholerae O1 strains and distinguishing them from strains of V. cholerae non-O1. J Clin Microbiol. 1994 Jan;32(1):235–237. doi: 10.1128/jcm.32.1.235-237.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Levine M. M., Black R. E., Clements M. L., Cisneros L., Nalin D. R., Young C. R. Duration of infection-derived immunity to cholera. J Infect Dis. 1981 Jun;143(6):818–820. doi: 10.1093/infdis/143.6.818. [DOI] [PubMed] [Google Scholar]
  192. Levine M. M., Black R. E., Clements M. L., Cisneros L., Saah A., Nalin D. R., Gill D. M., Craig J. P., Young C. R., Ristaino P. The pathogenicity of nonenterotoxigenic Vibrio cholerae serogroup O1 biotype El Tor isolated from sewage water in Brazil. J Infect Dis. 1982 Mar;145(3):296–299. doi: 10.1093/infdis/145.3.296. [DOI] [PubMed] [Google Scholar]
  193. Levine M. M., Black R. E., Clements M. L., Lanata C., Sears S., Honda T., Young C. R., Finkelstein R. A. Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine. Infect Immun. 1984 Feb;43(2):515–522. doi: 10.1128/iai.43.2.515-522.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  194. Levine M. M., Kaper J. B., Black R. E., Clements M. L. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol Rev. 1983 Dec;47(4):510–550. doi: 10.1128/mr.47.4.510-550.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Levine M. M., Kaper J. B., Herrington D., Ketley J., Losonsky G., Tacket C. O., Tall B., Cryz S. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet. 1988 Aug 27;2(8609):467–470. doi: 10.1016/s0140-6736(88)90120-1. [DOI] [PubMed] [Google Scholar]
  196. Levine M. M., Kaper J. B., Herrington D., Losonsky G., Morris J. G., Clements M. L., Black R. E., Tall B., Hall R. Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun. 1988 Jan;56(1):161–167. doi: 10.1128/iai.56.1.161-167.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Levine M. M., Kaper J. B. Live oral vaccines against cholera: an update. Vaccine. 1993;11(2):207–212. doi: 10.1016/0264-410x(93)90019-t. [DOI] [PubMed] [Google Scholar]
  198. Levine M. M., Nalin D. R., Craig J. P., Hoover D., Bergquist E. J., Waterman D., Holley H. P., Hornick R. B., Pierce N. P., Libonati J. P. Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity. Trans R Soc Trop Med Hyg. 1979;73(1):3–9. doi: 10.1016/0035-9203(79)90119-6. [DOI] [PubMed] [Google Scholar]
  199. Levine M. M., Nalin D. R., Rennels M. B., Hornick R. B., Sotman S., Van Blerk G., Hughes T. P., O'Donnell S., Barua D. Genetic susceptibility to cholera. Ann Hum Biol. 1979 Jul-Aug;6(4):369–374. doi: 10.1080/03014467900003751. [DOI] [PubMed] [Google Scholar]
  200. Levine M. M., Young C. R., Black R. E., Takeda Y., Finkelstein R. A. Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology. J Clin Microbiol. 1985 Feb;21(2):174–179. doi: 10.1128/jcm.21.2.174-179.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  201. Levine M. M., Young C. R., Hughes T. P., O'Donnell S., Black R. E., Clements M. L., Robins-Browne R., Lim Y. L. Duration of serum antitoxin response following Vibrio cholerae infection in North Americans: relevance for seroepidemiology. Am J Epidemiol. 1981 Sep;114(3):348–354. doi: 10.1093/oxfordjournals.aje.a113201. [DOI] [PubMed] [Google Scholar]
  202. Lin F. Y., Morris J. G., Jr, Kaper J. B., Gross T., Michalski J., Morrison C., Libonati J. P., Israel E. Persistence of cholera in the United States: isolation of Vibrio cholerae O1 from a patient with diarrhea in Maryland. J Clin Microbiol. 1986 Mar;23(3):624–626. doi: 10.1128/jcm.23.3.624-626.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  203. Lockman H. A., Galen J. E., Kaper J. B. Vibrio cholerae enterotoxin genes: nucleotide sequence analysis of DNA encoding ADP-ribosyltransferase. J Bacteriol. 1984 Sep;159(3):1086–1089. doi: 10.1128/jb.159.3.1086-1089.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  204. Lockman H., Kaper J. B. Nucleotide sequence analysis of the A2 and B subunits of Vibrio cholerae enterotoxin. J Biol Chem. 1983 Nov 25;258(22):13722–13726. [PubMed] [Google Scholar]
  205. Lowry P. W., Pavia A. T., McFarland L. M., Peltier B. H., Barrett T. J., Bradford H. B., Quan J. M., Lynch J., Mathison J. B., Gunn R. A. Cholera in Louisiana. Widening spectrum of seafood vehicles. Arch Intern Med. 1989 Sep;149(9):2079–2084. doi: 10.1001/archinte.149.9.2079. [DOI] [PubMed] [Google Scholar]
  206. Lycke N., Holmgren J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology. 1986 Oct;59(2):301–308. [PMC free article] [PubMed] [Google Scholar]
  207. Lycke N., Karlsson U., Sjölander A., Magnusson K. E. The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens. Scand J Immunol. 1991 Jun;33(6):691–698. doi: 10.1111/j.1365-3083.1991.tb02542.x. [DOI] [PubMed] [Google Scholar]
  208. Lycke N., Strober W. Cholera toxin promotes B cell isotype differentiation. J Immunol. 1989 Jun 1;142(11):3781–3787. [PubMed] [Google Scholar]
  209. Lycke N., Tsuji T., Holmgren J. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur J Immunol. 1992 Sep;22(9):2277–2281. doi: 10.1002/eji.1830220915. [DOI] [PubMed] [Google Scholar]
  210. Lång H. A., Palva E. T. A major outer membrane protein in Vibrio cholerae is maltose-inducible. Microb Pathog. 1987 Aug;3(2):143–147. doi: 10.1016/0882-4010(87)90072-6. [DOI] [PubMed] [Google Scholar]
  211. Lång H., Palva E. T. The ompS gene of Vibrio cholerae encodes a growth-phase-dependent maltoporin. Mol Microbiol. 1993 Nov;10(4):891–901. doi: 10.1111/j.1365-2958.1993.tb00960.x. [DOI] [PubMed] [Google Scholar]
  212. Madara J. L. Loosening tight junctions. Lessons from the intestine. J Clin Invest. 1989 Apr;83(4):1089–1094. doi: 10.1172/JCI113987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  213. Manoil C., Beckwith J. TnphoA: a transposon probe for protein export signals. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8129–8133. doi: 10.1073/pnas.82.23.8129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  214. Mathias J. R., Carlson G. M., DiMarino A. J., Bertiger G., Morton H. E., Cohen S. Intestinal myoelectric activity in response to live Vibrio cholerae and cholera enterotoxin. J Clin Invest. 1976 Jul;58(1):91–96. doi: 10.1172/JCI108464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  215. McCardell B. A., Madden J. M., Shah D. B. Isolation and characterization of a cytolysin produced by Vibrio cholerae serogroup non-O1. Can J Microbiol. 1985 Aug;31(8):711–720. doi: 10.1139/m85-135. [DOI] [PubMed] [Google Scholar]
  216. McCormack W. M., Chowdhury A. M., Jahangir N., Ahmed A. B., Mosley W. H. Tetracycline prophylaxis in families of cholera patients. Bull World Health Organ. 1968;38(5):787–792. [PMC free article] [PubMed] [Google Scholar]
  217. Mekalanos J. J. Cholera toxin: genetic analysis, regulation, and role in pathogenesis. Curr Top Microbiol Immunol. 1985;118:97–118. doi: 10.1007/978-3-642-70586-1_6. [DOI] [PubMed] [Google Scholar]
  218. Mekalanos J. J. Duplication and amplification of toxin genes in Vibrio cholerae. Cell. 1983 Nov;35(1):253–263. doi: 10.1016/0092-8674(83)90228-3. [DOI] [PubMed] [Google Scholar]
  219. Mekalanos J. J., Swartz D. J., Pearson G. D., Harford N., Groyne F., de Wilde M. Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development. Nature. 1983 Dec 8;306(5943):551–557. doi: 10.1038/306551a0. [DOI] [PubMed] [Google Scholar]
  220. Michalski J., Galen J. E., Fasano A., Kaper J. B. CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain. Infect Immun. 1993 Oct;61(10):4462–4468. doi: 10.1128/iai.61.10.4462-4468.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  221. Miller-Podraza H., Bradley R. M., Fishman P. H. Biosynthesis and localization of gangliosides in cultured cells. Biochemistry. 1982 Jul 6;21(14):3260–3265. doi: 10.1021/bi00257a002. [DOI] [PubMed] [Google Scholar]
  222. Miller C. J., Feachem R. G., Drasar B. S. Cholera epidemiology in developed and developing countries: new thoughts on transmission, seasonality, and control. Lancet. 1985 Feb 2;1(8423):261–262. doi: 10.1016/s0140-6736(85)91036-0. [DOI] [PubMed] [Google Scholar]
  223. Miller J. F., Mekalanos J. J., Falkow S. Coordinate regulation and sensory transduction in the control of bacterial virulence. Science. 1989 Feb 17;243(4893):916–922. doi: 10.1126/science.2537530. [DOI] [PubMed] [Google Scholar]
  224. Miller V. L., Mekalanos J. J. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol. 1988 Jun;170(6):2575–2583. doi: 10.1128/jb.170.6.2575-2583.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  225. Miller V. L., Mekalanos J. J. Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3471–3475. doi: 10.1073/pnas.81.11.3471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  226. Miller V. L., Taylor R. K., Mekalanos J. J. Cholera toxin transcriptional activator toxR is a transmembrane DNA binding protein. Cell. 1987 Jan 30;48(2):271–279. doi: 10.1016/0092-8674(87)90430-2. [DOI] [PubMed] [Google Scholar]
  227. Minami A., Hashimoto S., Abe H., Arita M., Taniguchi T., Honda T., Miwatani T., Nishibuchi M. Cholera enterotoxin production in Vibrio cholerae O1 strains isolated from the environment and from humans in Japan. Appl Environ Microbiol. 1991 Aug;57(8):2152–2157. doi: 10.1128/aem.57.8.2152-2157.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  228. Momen H., Salles C. A. Enzyme markers for Vibrio cholerae: identification of classical, El Tor and environmental strains. Trans R Soc Trop Med Hyg. 1985;79(6):773–776. doi: 10.1016/0035-9203(85)90113-0. [DOI] [PubMed] [Google Scholar]
  229. Morris J. G., Jr, Black R. E. Cholera and other vibrioses in the United States. N Engl J Med. 1985 Feb 7;312(6):343–350. doi: 10.1056/NEJM198502073120604. [DOI] [PubMed] [Google Scholar]
  230. Morris J. G., Jr Non-O group 1 Vibrio cholerae: a look at the epidemiology of an occasional pathogen. Epidemiol Rev. 1990;12:179–191. doi: 10.1093/oxfordjournals.epirev.a036052. [DOI] [PubMed] [Google Scholar]
  231. Morris J. G., Jr, Picardi J. L., Lieb S., Lee J. V., Roberts A., Hood M., Gunn R. A., Blake P. A. Isolation of nontoxigenic Vibrio cholerae O group 1 from a patient with severe gastrointestinal disease. J Clin Microbiol. 1984 Feb;19(2):296–297. doi: 10.1128/jcm.19.2.296-297.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  232. Morris J. G., Jr, Takeda T., Tall B. D., Losonsky G. A., Bhattacharya S. K., Forrest B. D., Kay B. A., Nishibuchi M. Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans. J Clin Invest. 1990 Mar;85(3):697–705. doi: 10.1172/JCI114494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. Morris J. G., Jr, Tenney J. H., Drusano G. L. In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents. Antimicrob Agents Chemother. 1985 Sep;28(3):442–445. doi: 10.1128/aac.28.3.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  234. Morris J. G., Jr, Wilson R., Davis B. R., Wachsmuth I. K., Riddle C. F., Wathen H. G., Pollard R. A., Blake P. A. Non-O group 1 Vibrio cholerae gastroenteritis in the United States: clinical, epidemiologic, and laboratory characteristics of sporadic cases. Ann Intern Med. 1981 May;94(5):656–658. doi: 10.7326/0003-4819-94-5-656. [DOI] [PubMed] [Google Scholar]
  235. Moseley S. L., Falkow S. Nucleotide sequence homology between the heat-labile enterotoxin gene of Escherichia coli and Vibrio cholerae deoxyribonucleic acid. J Bacteriol. 1980 Oct;144(1):444–446. doi: 10.1128/jb.144.1.444-446.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  236. Mosley W. H., McCormack W. M., Ahmed A., Chowdhury A. K., Barui R. K. Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 2. Results of the serological surveys in the study population--the relationship of case rate to antibody titre and an estimate of the inapparent infection rate with Vibrio cholerae. Bull World Health Organ. 1969;40(2):187–197. [PMC free article] [PubMed] [Google Scholar]
  237. Moss J., Vaughan M. Activation of cholera toxin and Escherichia coli heat-labile enterotoxins by ADP-ribosylation factors, a family of 20 kDa guanine nucleotide-binding proteins. Mol Microbiol. 1991 Nov;5(11):2621–2627. doi: 10.1111/j.1365-2958.1991.tb01971.x. [DOI] [PubMed] [Google Scholar]
  238. Moss J., Vaughan M. Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor. J Biol Chem. 1977 Apr 10;252(7):2455–2457. [PubMed] [Google Scholar]
  239. Mostow P., Richardson K. High-frequency spontaneous mutation of classical Vibrio cholerae to a nonmotile phenotype. Infect Immun. 1990 Nov;58(11):3633–3639. doi: 10.1128/iai.58.11.3633-3639.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  240. Motes M. L., Jr, Zywno S. R., DePaola A., Becker R. E., Presnell M. W. Isolation of Vibrio cholerae serotype Ogawa from a Florida estuary. Appl Environ Microbiol. 1983 Jan;45(1):321–322. doi: 10.1128/aem.45.1.321-322.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  241. Muñoz E., Zubiaga A. M., Merrow M., Sauter N. P., Huber B. T. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J Exp Med. 1990 Jul 1;172(1):95–103. doi: 10.1084/jem.172.1.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  242. Nakasone N., Iwanaga M. Pili of Vibrio cholerae non-O1. Infect Immun. 1990 Jun;58(6):1640–1646. doi: 10.1128/iai.58.6.1640-1646.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  243. Nalin D. R., Daya V., Reid A., Levine M. M., Cisneros L. Adsorption and growth of Vibrio cholerae on chitin. Infect Immun. 1979 Aug;25(2):768–770. doi: 10.1128/iai.25.2.768-770.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  244. Nalin D. R., Levine M. M., Hornick R. B., Bergquist E. J., Hoover D., Holley H. P., Waterman D., VanBlerk J., Matheny S., Sotman S. The problem of emesis during oral glucose-electrolytes therapy given from the onset of severe cholera. Trans R Soc Trop Med Hyg. 1979;73(1):10–14. doi: 10.1016/0035-9203(79)90120-2. [DOI] [PubMed] [Google Scholar]
  245. Nambiar M. P., Oda T., Chen C., Kuwazuru Y., Wu H. C. Involvement of the Golgi region in the intracellular trafficking of cholera toxin. J Cell Physiol. 1993 Feb;154(2):222–228. doi: 10.1002/jcp.1041540203. [DOI] [PubMed] [Google Scholar]
  246. Nath G., Sanyal S. C. Emergence of Vibrio cholerae O1 resistant to vibriostatic agent 0/129. Lancet. 1992 Aug 8;340(8815):366–367. doi: 10.1016/0140-6736(92)91438-e. [DOI] [PubMed] [Google Scholar]
  247. Nilsson O., Cassuto J., Larsson P. A., Jodal M., Lidberg P., Ahlman H., Dahlström A., Lundgren O. 5-Hydroxytryptamine and cholera secretion: a histochemical and physiological study in cats. Gut. 1983 Jun;24(6):542–548. doi: 10.1136/gut.24.6.542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  248. Nishibuchi M., Fasano A., Russell R. G., Kaper J. B. Enterotoxigenicity of Vibrio parahaemolyticus with and without genes encoding thermostable direct hemolysin. Infect Immun. 1992 Sep;60(9):3539–3545. doi: 10.1128/iai.60.9.3539-3545.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  249. O'Brien A. D., Chen M. E., Holmes R. K., Kaper J., Levine M. M. Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin. Lancet. 1984 Jan 14;1(8368):77–78. doi: 10.1016/s0140-6736(84)90006-0. [DOI] [PubMed] [Google Scholar]
  250. O'Brien A. D., Kapral F. A. Increased cyclic adenosine 3',5'-monophosphate content in guinea pig ileum after exposure to Staphylococcus aureus delta-toxin. Infect Immun. 1976 Jan;13(1):152–162. doi: 10.1128/iai.13.1.152-162.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  251. Ogawa A., Kato J., Watanabe H., Nair B. G., Takeda T. Cloning and nucleotide sequence of a heat-stable enterotoxin gene from Vibrio cholerae non-O1 isolated from a patient with traveler's diarrhea. Infect Immun. 1990 Oct;58(10):3325–3329. doi: 10.1128/iai.58.10.3325-3329.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  252. Ogawa A., Takeda T. The gene encoding the heat-stable enterotoxin of Vibrio cholerae is flanked by 123-base pair direct repeats. Microbiol Immunol. 1993;37(8):607–616. doi: 10.1111/j.1348-0421.1993.tb01683.x. [DOI] [PubMed] [Google Scholar]
  253. Ogierman M. A., Manning P. A. Homology of TcpN, a putative regulatory protein of Vibrio cholerae, to the AraC family of transcriptional activators. Gene. 1992 Jul 1;116(1):93–97. doi: 10.1016/0378-1119(92)90634-2. [DOI] [PubMed] [Google Scholar]
  254. Ogierman M. A., Manning P. A. TCP pilus biosynthesis in Vibrio cholerae O1: gene sequence of tcpC encoding an outer membrane lipoprotein. FEMS Microbiol Lett. 1992 Oct 1;76(1-2):179–184. doi: 10.1016/0378-1097(92)90383-y. [DOI] [PubMed] [Google Scholar]
  255. Ogierman M. A., Zabihi S., Mourtzios L., Manning P. A. Genetic organization and sequence of the promoter-distal region of the tcp gene cluster of Vibrio cholerae. Gene. 1993 Apr 15;126(1):51–60. doi: 10.1016/0378-1119(93)90589-u. [DOI] [PubMed] [Google Scholar]
  256. Olsvik O., Wahlberg J., Petterson B., Uhlén M., Popovic T., Wachsmuth I. K., Fields P. I. Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains. J Clin Microbiol. 1993 Jan;31(1):22–25. doi: 10.1128/jcm.31.1.22-25.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  257. Osek J., Svennerholm A. M., Holmgren J. Protection against Vibrio cholerae El Tor infection by specific antibodies against mannose-binding hemagglutinin pili. Infect Immun. 1992 Nov;60(11):4961–4964. doi: 10.1128/iai.60.11.4961-4964.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  258. Owen R. L., Pierce N. F., Apple R. T., Cray W. C., Jr M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration. J Infect Dis. 1986 Jun;153(6):1108–1118. doi: 10.1093/infdis/153.6.1108. [DOI] [PubMed] [Google Scholar]
  259. Pal A., Ramamurthy T., Bhadra R. K., Takeda T., Shimada T., Takeda Y., Nair G. B., Pal S. C., Chakrabarti S. Reassessment of the prevalence of heat-stable enterotoxin (NAG-ST) among environmental Vibrio cholerae non-O1 strains isolated from Calcutta, India, by using a NAG-ST DNA probe. Appl Environ Microbiol. 1992 Aug;58(8):2485–2489. doi: 10.1128/aem.58.8.2485-2489.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  260. Parsot C., Mekalanos J. J. Expression of ToxR, the transcriptional activator of the virulence factors in Vibrio cholerae, is modulated by the heat shock response. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9898–9902. doi: 10.1073/pnas.87.24.9898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  261. Parsot C., Taxman E., Mekalanos J. J. ToxR regulates the production of lipoproteins and the expression of serum resistance in Vibrio cholerae. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1641–1645. doi: 10.1073/pnas.88.5.1641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  262. Payne S. M., Finkelstein R. A. Siderophore production by Vibrio cholerae. Infect Immun. 1978 Apr;20(1):310–311. doi: 10.1128/iai.20.1.310-311.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  263. Pearson G. D., DiRita V. J., Goldberg M. B., Boyko S. A., Calderwood S. B., Mekalanos J. J. New attenuated derivatives of Vibrio cholerae. Res Microbiol. 1990 Sep-Oct;141(7-8):893–899. doi: 10.1016/0923-2508(90)90127-c. [DOI] [PubMed] [Google Scholar]
  264. Pearson G. D., Mekalanos J. J. Molecular cloning of Vibrio cholerae enterotoxin genes in Escherichia coli K-12. Proc Natl Acad Sci U S A. 1982 May;79(9):2976–2980. doi: 10.1073/pnas.79.9.2976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  265. Pearson G. D., Woods A., Chiang S. L., Mekalanos J. J. CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3750–3754. doi: 10.1073/pnas.90.8.3750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  266. Peek J. A., Taylor R. K. Characterization of a periplasmic thiol:disulfide interchange protein required for the functional maturation of secreted virulence factors of Vibrio cholerae. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6210–6214. doi: 10.1073/pnas.89.13.6210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  267. Peltola H., Siitonen A., Kyrönseppä H., Simula I., Mattila L., Oksanen P., Kataja M. J., Cadoz M. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet. 1991 Nov 23;338(8778):1285–1289. doi: 10.1016/0140-6736(91)92590-x. [DOI] [PubMed] [Google Scholar]
  268. Peterson J. W., Hejtmancik K. E., Markel D. E., Craig J. P., Kurosky A. Antigenic specificity of neutralizing antibody to cholera toxin. Infect Immun. 1979 Jun;24(3):774–779. doi: 10.1128/iai.24.3.774-779.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  269. Peterson J. W., Ochoa L. G. Role of prostaglandins and cAMP in the secretory effects of cholera toxin. Science. 1989 Aug 25;245(4920):857–859. doi: 10.1126/science.2549637. [DOI] [PubMed] [Google Scholar]
  270. Peterson J. W., Reitmeyer J. C., Jackson C. A., Ansari G. A. Protein synthesis is required for cholera toxin-induced stimulation of arachidonic acid metabolism. Biochim Biophys Acta. 1991 Mar 19;1092(1):79–84. doi: 10.1016/0167-4889(91)90179-2. [DOI] [PubMed] [Google Scholar]
  271. Peterson J. W. Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine. Infect Immun. 1979 Nov;26(2):528–533. doi: 10.1128/iai.26.2.528-533.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  272. Peterson K. M., Mekalanos J. J. Characterization of the Vibrio cholerae ToxR regulon: identification of novel genes involved in intestinal colonization. Infect Immun. 1988 Nov;56(11):2822–2829. doi: 10.1128/iai.56.11.2822-2829.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  273. Pierce N. F., Cray W. C., Jr, Sacci J. B., Jr Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanisms. Infect Immun. 1982 Aug;37(2):687–694. doi: 10.1128/iai.37.2.687-694.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  274. Pierce N. F. Differential inhibitory effects of cholera toxoids and ganglioside on the enterotoxins of Vibrio cholerae and Escherichia coli. J Exp Med. 1973 Apr 1;137(4):1009–1023. doi: 10.1084/jem.137.4.1009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  275. Pierce N. F., Kaper J. B., Mekalanos J. J., Cray W. C., Jr Role of cholera toxin in enteric colonization by Vibrio cholerae O1 in rabbits. Infect Immun. 1985 Dec;50(3):813–816. doi: 10.1128/iai.50.3.813-816.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  276. Pohlner J., Meyer T. F., Jalajakumari M. B., Manning P. A. Nucleotide sequence of ompV, the gene for a major Vibrio cholerae outer membrane protein. Mol Gen Genet. 1986 Dec;205(3):494–500. doi: 10.1007/BF00338088. [DOI] [PubMed] [Google Scholar]
  277. Popovic T., Bopp C., Olsvik O., Wachsmuth K. Epidemiologic application of a standardized ribotype scheme for Vibrio cholerae O1. J Clin Microbiol. 1993 Sep;31(9):2474–2482. doi: 10.1128/jcm.31.9.2474-2482.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  278. Rahman M., Sack D. A., Wadood A., Yasmin M., Latif A. Rapid identification of Vibrio cholerae serotype O1 from primary isolation plates by a coagglutination test. J Med Microbiol. 1989 Jan;28(1):39–41. doi: 10.1099/00222615-28-1-39. [DOI] [PubMed] [Google Scholar]
  279. Ramamurthy T., Bhattacharya S. K., Uesaka Y., Horigome K., Paul M., Sen D., Pal S. C., Takeda T., Takeda Y., Nair G. B. Evaluation of the bead enzyme-linked immunosorbent assay for detection of cholera toxin directly from stool specimens. J Clin Microbiol. 1992 Jul;30(7):1783–1786. doi: 10.1128/jcm.30.7.1783-1786.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  280. Ramamurthy T., Garg S., Sharma R., Bhattacharya S. K., Nair G. B., Shimada T., Takeda T., Karasawa T., Kurazano H., Pal A. Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet. 1993 Mar 13;341(8846):703–704. doi: 10.1016/0140-6736(93)90480-5. [DOI] [PubMed] [Google Scholar]
  281. Ramamurthy T., Pal A., Bag P. K., Bhattacharya S. K., Nair G. B., Kurozano H., Yamasaki S., Shirai H., Takeda T., Uesaka Y. Detection of cholera toxin gene in stool specimens by polymerase chain reaction: comparison with bead enzyme-linked immunosorbent assay and culture method for laboratory diagnosis of cholera. J Clin Microbiol. 1993 Nov;31(11):3068–3070. doi: 10.1128/jcm.31.11.3068-3070.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  282. Ramamurthy T., Pal A., Bhattacharya M. K., Bhattacharya S. K., Chowdhury A. S., Takeda Y., Takeda T., Pal S. C., Nair G. B. Serovar, biotype, phage type, toxigenicity & antibiotic susceptibility patterns of Vibrio cholerae isolated during two consecutive cholera seasons (1989-90) in Calcutta. Indian J Med Res. 1992 May;95:125–129. [PubMed] [Google Scholar]
  283. Ramamurthy T., Pal A., Pal S. C., Nair G. B. Taxonomical implications of the emergence of high frequency of occurrence of 2,4-diamino-6,7-diisopropylpteridine-resistant strains of Vibrio cholerae from clinical cases of cholera in Calcutta, India. J Clin Microbiol. 1992 Mar;30(3):742–743. doi: 10.1128/jcm.30.3.742-743.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  284. Redmond J. W. The structure of the O-antigenic side chain of the lipopolysaccharide of Vibrio cholerae 569B (Inaba). Biochim Biophys Acta. 1979 May 1;584(2):346–352. doi: 10.1016/0304-4165(79)90280-0. [DOI] [PubMed] [Google Scholar]
  285. Reitmeyer J. C., Peterson J. W. Stimulatory effects of cholera toxin on arachidonic acid metabolism in Chinese hamster ovary cells. Proc Soc Exp Biol Med. 1990 Mar;193(3):181–184. doi: 10.3181/00379727-193-43022. [DOI] [PubMed] [Google Scholar]
  286. Rennels M. B., Levine M. M., Daya V., Angle P., Young C. Selective vs. nonselective media and direct plating vs. enrichment technique in isolation of Vibrio cholerae: recommendations for clinical laboratories. J Infect Dis. 1980 Sep;142(3):328–331. doi: 10.1093/infdis/142.3.328. [DOI] [PubMed] [Google Scholar]
  287. Rhine J. A., Taylor R. K. TcpA pilin sequences and colonization requirements for O1 and O139 vibrio cholerae. Mol Microbiol. 1994 Sep;13(6):1013–1020. doi: 10.1111/j.1365-2958.1994.tb00492.x. [DOI] [PubMed] [Google Scholar]
  288. Rice E. W., Johnson C. J., Clark R. M., Fox K. R., Reasoner D. J., Dunnigan M. E., Panigrahi P., Johnson J. A., Morris J. G., Jr Chlorine and survival of "rugose" Vibrio cholerae. Lancet. 1992 Sep 19;340(8821):740–740. doi: 10.1016/0140-6736(92)92289-r. [DOI] [PubMed] [Google Scholar]
  289. Richardson K., Kaper J. B., Levine M. M. Human immune response to Vibrio cholerae O1 whole cells and isolated outer membrane antigens. Infect Immun. 1989 Feb;57(2):495–501. doi: 10.1128/iai.57.2.495-501.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  290. Richardson K., Michalski J., Kaper J. B. Hemolysin production and cloning of two hemolysin determinants from classical Vibrio cholerae. Infect Immun. 1986 Nov;54(2):415–420. doi: 10.1128/iai.54.2.415-420.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  291. Richardson K., Parker C. D. Identification and occurrence of Vibrio cholerae flagellar core proteins in isolated outer membrane. Infect Immun. 1985 Mar;47(3):674–679. doi: 10.1128/iai.47.3.674-679.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  292. Richardson K. Roles of motility and flagellar structure in pathogenicity of Vibrio cholerae: analysis of motility mutants in three animal models. Infect Immun. 1991 Aug;59(8):2727–2736. doi: 10.1128/iai.59.8.2727-2736.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  293. Richardson S. H. Factors influencing in vitro skin permeability factor production by Vibrio cholerae. J Bacteriol. 1969 Oct;100(1):27–34. doi: 10.1128/jb.100.1.27-34.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  294. Richardson S. H., Giles J. C., Kruger K. S. Sealed adult mice: new model for enterotoxin evaluation. Infect Immun. 1984 Feb;43(2):482–486. doi: 10.1128/iai.43.2.482-486.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  295. Ries A. A., Vugia D. J., Beingolea L., Palacios A. M., Vasquez E., Wells J. G., Garcia Baca N., Swerdlow D. L., Pollack M., Bean N. H. Cholera in Piura, Peru: a modern urban epidemic. J Infect Dis. 1992 Dec;166(6):1429–1433. doi: 10.1093/infdis/166.6.1429. [DOI] [PubMed] [Google Scholar]
  296. Roberts A. B., Harris J. R., Taitai T., Taraam T., Tekanene J., Cati A., Flood T., Teburae M. Cholera in the Gilbert Islands. II. Clinical and laboratory findings. Am J Trop Med Hyg. 1979 Jul;28(4):685–691. [PubMed] [Google Scholar]
  297. Robins-Browne R. M., Young C. R., Levine M. M., Craig J. P. Microtiter enzyme-linked immunosorbent assay for immunoglobulin g cholera antitoxin in humans: sensitivity and specificity. Infect Immun. 1980 Feb;27(2):497–500. doi: 10.1128/iai.27.2.497-500.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  298. Rodman D. M., Zamudio S. The cystic fibrosis heterozygote--advantage in surviving cholera? Med Hypotheses. 1991 Nov;36(3):253–258. doi: 10.1016/0306-9877(91)90144-n. [DOI] [PubMed] [Google Scholar]
  299. Roszak D. B., Colwell R. R. Survival strategies of bacteria in the natural environment. Microbiol Rev. 1987 Sep;51(3):365–379. doi: 10.1128/mr.51.3.365-379.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  300. Sack R. B., Carpenter C. C. Experimental canine cholera. I. Development of the model. J Infect Dis. 1969 Feb;119(2):138–149. doi: 10.1093/infdis/119.2.138. [DOI] [PubMed] [Google Scholar]
  301. Sack R. B., Miller C. E. Progressive changes of Vibrio serotypes in germ-free mice infected with Vibrio cholerae. J Bacteriol. 1969 Sep;99(3):688–695. doi: 10.1128/jb.99.3.688-695.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  302. Saha S., Sanyal S. C. Immunobiological relationships of the enterotoxins produced by cholera toxin gene-positive (CT+) and -negative (CT-) strains of Vibrio cholerae O1. J Med Microbiol. 1990 May;32(1):33–37. doi: 10.1099/00222615-32-1-33. [DOI] [PubMed] [Google Scholar]
  303. Sakazaki R., Shimada T. Serovars of Vibrio cholerae identified during 1970-1975. Jpn J Med Sci Biol. 1977 Oct;30(5):279–282. doi: 10.7883/yoken1952.30.279. [DOI] [PubMed] [Google Scholar]
  304. Sanchez J., Johansson S., Löwenadler B., Svennerholm A. M., Holmgren J. Recombinant cholera toxin B subunit and gene fusion proteins for oral vaccination. Res Microbiol. 1990 Sep-Oct;141(7-8):971–979. doi: 10.1016/0923-2508(90)90137-f. [DOI] [PubMed] [Google Scholar]
  305. Sanyal S. C., Alam K., Neogi P. K., Huq M. I., Al-Mahmud K. A. A new cholera toxin. Lancet. 1983 Jun 11;1(8337):1337–1337. doi: 10.1016/s0140-6736(83)92449-2. [DOI] [PubMed] [Google Scholar]
  306. Schrank G. D., Verwey W. F. Distribution of cholera organisms in experimental Vibrio cholerae infections: proposed mechanisms of pathogenesis and antibacterial immunity. Infect Immun. 1976 Jan;13(1):195–203. doi: 10.1128/iai.13.1.195-203.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  307. Schödel F., Will H., Johansson S., Sanchez J., Holmgren J. Synthesis in Vibrio cholerae and secretion of hepatitis B virus antigens fused to Escherichia coli heat-labile enterotoxin subunit B. Gene. 1991 Mar 15;99(2):255–259. doi: 10.1016/0378-1119(91)90135-x. [DOI] [PubMed] [Google Scholar]
  308. Sciortino C. V., Finkelstein R. A. Vibrio cholerae expresses iron-regulated outer membrane proteins in vivo. Infect Immun. 1983 Dec;42(3):990–996. doi: 10.1128/iai.42.3.990-996.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  309. Sears S. D., Richardson K., Young C., Parker C. D., Levine M. M. Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae. Infect Immun. 1984 May;44(2):439–444. doi: 10.1128/iai.44.2.439-444.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  310. Selander R. K., Caugant D. A., Ochman H., Musser J. M., Gilmour M. N., Whittam T. S. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol. 1986 May;51(5):873–884. doi: 10.1128/aem.51.5.873-884.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  311. Sengupta D. K., Sengupta T. K., Ghose A. C. Major outer membrane proteins of Vibrio cholerae and their role in induction of protective immunity through inhibition of intestinal colonization. Infect Immun. 1992 Nov;60(11):4848–4855. doi: 10.1128/iai.60.11.4848-4855.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  312. Shandera W. X., Hafkin B., Martin D. L., Taylor J. P., Maserang D. L., Wells J. G., Kelly M., Ghandi K., Kaper J. B., Lee J. V. Persistence of cholera in the United States. Am J Trop Med Hyg. 1983 Jul;32(4):812–817. doi: 10.4269/ajtmh.1983.32.812. [DOI] [PubMed] [Google Scholar]
  313. Sharma D. P., Stroeher U. H., Thomas C. J., Manning P. A., Attridge S. R. The toxin-coregulated pilus (TCP) of Vibrio cholerae: molecular cloning of genes involved in pilus biosynthesis and evaluation of TCP as a protective antigen in the infant mouse model. Microb Pathog. 1989 Dec;7(6):437–448. doi: 10.1016/0882-4010(89)90024-7. [DOI] [PubMed] [Google Scholar]
  314. Shaw C. E., Taylor R. K. Vibrio cholerae O395 tcpA pilin gene sequence and comparison of predicted protein structural features to those of type 4 pilins. Infect Immun. 1990 Sep;58(9):3042–3049. doi: 10.1128/iai.58.9.3042-3049.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  315. Shimada T., Sakazaki R., Fujimura S., Niwano K., Mishina M., Takizawa K. A new selective, differential agar medium for isolation of Vibrio cholerae O1: PMT (polymyxin-mannose-tellurite) agar. Jpn J Med Sci Biol. 1990 Apr;43(2):37–41. doi: 10.7883/yoken1952.43.37. [DOI] [PubMed] [Google Scholar]
  316. Shimada T., Sakazaki R. R antigen of vibrio cholerae. Jpn J Med Sci Biol. 1973 Aug;26(4):155–160. doi: 10.7883/yoken1952.26.155. [DOI] [PubMed] [Google Scholar]
  317. Shirai H., Nishibuchi M., Ramamurthy T., Bhattacharya S. K., Pal S. C., Takeda Y. Polymerase chain reaction for detection of the cholera enterotoxin operon of Vibrio cholerae. J Clin Microbiol. 1991 Nov;29(11):2517–2521. doi: 10.1128/jcm.29.11.2517-2521.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  318. Siddique A. K., Baqui A. H., Eusof A., Haider K., Hossain M. A., Bashir I., Zaman K. Survival of classic cholera in Bangladesh. Lancet. 1991 May 11;337(8750):1125–1127. doi: 10.1016/0140-6736(91)92789-5. [DOI] [PubMed] [Google Scholar]
  319. Sigel S. P., Payne S. M. Effect of iron limitation on growth, siderophore production, and expression of outer membrane proteins of Vibrio cholerae. J Bacteriol. 1982 Apr;150(1):148–155. doi: 10.1128/jb.150.1.148-155.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  320. Sigel S. P., Stoebner J. A., Payne S. M. Iron-vibriobactin transport system is not required for virulence of Vibrio cholerae. Infect Immun. 1985 Feb;47(2):360–362. doi: 10.1128/iai.47.2.360-362.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  321. Simonson J. G., Siebeling R. J. Coagglutination of Vibrio cholerae, Vibrio mimicus, and Vibrio vulnificus with anti-flagellar monoclonal antibody. J Clin Microbiol. 1988 Oct;26(10):1962–1966. doi: 10.1128/jcm.26.10.1962-1966.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  322. Sinha V. B., Jacob A., Srivastava R., Kaper J. B., Srivastava B. S. Identification of the flagellar antigens of Vibrio cholerae El Tor and their role in protection. Vaccine. 1993;11(3):372–375. doi: 10.1016/0264-410x(93)90202-9. [DOI] [PubMed] [Google Scholar]
  323. Sircar B. K., Dutta P., De S. P., Sikdar S. N., Deb B. C., Pal S. C., Mitra S. S. ABO blood group distributions in diarrhoea cases including cholera in Calcutta. Ann Hum Biol. 1981 May-Jun;8(3):289–291. doi: 10.1080/03014468100005061. [DOI] [PubMed] [Google Scholar]
  324. Sixma T. K., Pronk S. E., Kalk K. H., Wartna E. S., van Zanten B. A., Witholt B., Hol W. G. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature. 1991 May 30;351(6325):371–377. doi: 10.1038/351371a0. [DOI] [PubMed] [Google Scholar]
  325. Sjöqvist A., Cassuto J., Jodal M., Lundgren O. Actions of serotonin antagonists on cholera-toxin-induced intestinal fluid secretion. Acta Physiol Scand. 1992 Jul;145(3):229–237. doi: 10.1111/j.1748-1716.1992.tb09360.x. [DOI] [PubMed] [Google Scholar]
  326. Smith H. L., Jr Serotyping of non-cholera vibrios. J Clin Microbiol. 1979 Jul;10(1):85–90. doi: 10.1128/jcm.10.1.85-90.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  327. Smith H. W., Linggood M. A. Observations on the pathogenic properties of the K88, Hly and Ent plasmids of Escherichia coli with particular reference to porcine diarrhoea. J Med Microbiol. 1971 Nov;4(4):467–485. doi: 10.1099/00222615-4-4-467. [DOI] [PubMed] [Google Scholar]
  328. Snyder J. D., Allegra D. T., Levine M. M., Craig J. P., Feeley J. C., DeWitt W. E., Blake P. A. Serologic studies of naturally acquired infection with Vibrio cholerae serogroup O1 in the United States. J Infect Dis. 1981 Feb;143(2):182–187. doi: 10.1093/infdis/143.2.182. [DOI] [PubMed] [Google Scholar]
  329. Spangler B. D. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev. 1992 Dec;56(4):622–647. doi: 10.1128/mr.56.4.622-647.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  330. Speelman P., Rabbani G. H., Bukhave K., Rask-Madsen J. Increased jejunal prostaglandin E2 concentrations in patients with acute cholera. Gut. 1985 Feb;26(2):188–193. doi: 10.1136/gut.26.2.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  331. Spira W. M., Huq A., Ahmed Q. S., Saeed Y. A. Uptake of Vibrio cholerae biotype eltor from contaminated water by water hyacinth (eichornia crassipes). Appl Environ Microbiol. 1981 Sep;42(3):550–553. doi: 10.1128/aem.42.3.550-553.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  332. Spira W. M., Khan M. U., Saeed Y. A., Sattar M. A. Microbiological surveillance of intra-neighbourhood E1 Tor cholera transmission in rural Bangladesh. Bull World Health Organ. 1980;58(5):731–740. [PMC free article] [PubMed] [Google Scholar]
  333. Spira W. M., Sack R. B., Froehlich J. L. Simple adult rabbit model for Vibrio cholerae and enterotoxigenic Escherichia coli diarrhea. Infect Immun. 1981 May;32(2):739–747. doi: 10.1128/iai.32.2.739-747.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  334. St Louis M. E., Porter J. D., Helal A., Drame K., Hargrett-Bean N., Wells J. G., Tauxe R. V. Epidemic cholera in West Africa: the role of food handling and high-risk foods. Am J Epidemiol. 1990 Apr;131(4):719–728. doi: 10.1093/oxfordjournals.aje.a115556. [DOI] [PubMed] [Google Scholar]
  335. Stoebner J. A., Butterton J. R., Calderwood S. B., Payne S. M. Identification of the vibriobactin receptor of Vibrio cholerae. J Bacteriol. 1992 May;174(10):3270–3274. doi: 10.1128/jb.174.10.3270-3274.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  336. Stoebner J. A., Payne S. M. Iron-regulated hemolysin production and utilization of heme and hemoglobin by Vibrio cholerae. Infect Immun. 1988 Nov;56(11):2891–2895. doi: 10.1128/iai.56.11.2891-2895.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  337. Stroeher U. H., Karageorgos L. E., Morona R., Manning P. A. Serotype conversion in Vibrio cholerae O1. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2566–2570. doi: 10.1073/pnas.89.7.2566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  338. Su-Arehawaratana P., Singharaj P., Taylor D. N., Hoge C., Trofa A., Kuvanont K., Migasena S., Pitisuttitham P., Lim Y. L., Losonsky G. Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand. J Infect Dis. 1992 Jun;165(6):1042–1048. doi: 10.1093/infdis/165.6.1042. [DOI] [PubMed] [Google Scholar]
  339. Suharyono, Simanjuntak C., Witham N., Punjabi N., Heppner D. G., Losonsky G., Totosudirjo H., Rifai A. R., Clemens J., Lim Y. L. Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children. Lancet. 1992 Sep 19;340(8821):689–694. doi: 10.1016/0140-6736(92)92231-4. [DOI] [PubMed] [Google Scholar]
  340. Sun D. X., Mekalanos J. J., Taylor R. K. Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model. J Infect Dis. 1990 Jun;161(6):1231–1236. doi: 10.1093/infdis/161.6.1231. [DOI] [PubMed] [Google Scholar]
  341. Svennerholm A. M., Holmgren J. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid. Infect Immun. 1976 Mar;13(3):735–740. doi: 10.1128/iai.13.3.735-740.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  342. Svennerholm A. M., Strömberg G. J., Holmgren J. Purification of Vibrio cholerae soluble hemagglutinin and development of enzyme-linked immunosorbent assays for antigen and antibody quantitations. Infect Immun. 1983 Jul;41(1):237–243. doi: 10.1128/iai.41.1.237-243.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  343. Swaddiwudhipong W., Limpakarnjanarat K. An outbreak of El Tor cholera in an institution for the mentally retarded in Nonthaburi, June-July 1987. J Med Assoc Thai. 1991 Jun;74(6):306–310. [PubMed] [Google Scholar]
  344. Swerdlow D. L., Mintz E. D., Rodriguez M., Tejada E., Ocampo C., Espejo L., Greene K. D., Saldana W., Seminario L., Tauxe R. V. Waterborne transmission of epidemic cholera in Trujillo, Peru: lessons for a continent at risk. Lancet. 1992 Jul 4;340(8810):28–33. doi: 10.1016/0140-6736(92)92432-f. [DOI] [PubMed] [Google Scholar]
  345. Swerdlow D. L., Ries A. A. Cholera in the Americas. Guidelines for the clinician. JAMA. 1992 Mar 18;267(11):1495–1499. [PubMed] [Google Scholar]
  346. Swerdlow D. L., Ries A. A. Vibrio cholerae non-O1--the eighth pandemic? Lancet. 1993 Aug 14;342(8868):382–383. doi: 10.1016/0140-6736(93)92806-5. [DOI] [PubMed] [Google Scholar]
  347. Tabtieng R., Wattanasri S., Echeverria P., Seriwatana J., Bodhidatta L., Chatkaeomorakot A., Rowe B. An epidemic of Vibrio cholerae el tor Inaba resistant to several antibiotics with a conjugative group C plasmid coding for type II dihydrofolate reductase in Thailand. Am J Trop Med Hyg. 1989 Dec;41(6):680–686. doi: 10.4269/ajtmh.1989.41.680. [DOI] [PubMed] [Google Scholar]
  348. Tacket C. O., Clemens J., Kaper J. B. Cholera vaccines. Biotechnology. 1992;20:53–68. doi: 10.1016/b978-0-7506-9265-6.50009-9. [DOI] [PubMed] [Google Scholar]
  349. Tacket C. O., Forrest B., Morona R., Attridge S. R., LaBrooy J., Tall B. D., Reymann M., Rowley D., Levine M. M. Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a. Infect Immun. 1990 Jun;58(6):1620–1627. doi: 10.1128/iai.58.6.1620-1627.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  350. Tacket C. O., Losonsky G., Nataro J. P., Cryz S. J., Edelman R., Fasano A., Michalski J., Kaper J. B., Levine M. M. Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae. J Infect Dis. 1993 Dec;168(6):1536–1540. doi: 10.1093/infdis/168.6.1536. [DOI] [PubMed] [Google Scholar]
  351. Tacket C. O., Losonsky G., Nataro J. P., Cryz S. J., Edelman R., Kaper J. B., Levine M. M. Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR. J Infect Dis. 1992 Oct;166(4):837–841. doi: 10.1093/infdis/166.4.837. [DOI] [PubMed] [Google Scholar]
  352. Takeda T., Peina Y., Ogawa A., Dohi S., Abe H., Nair G. B., Pal S. C. Detection of heat-stable enterotoxin in a cholera toxin gene-positive strain of Vibrio cholerae O1. FEMS Microbiol Lett. 1991 May 1;64(1):23–27. doi: 10.1016/0378-1097(91)90203-m. [DOI] [PubMed] [Google Scholar]
  353. Takeya K., Otohuji T., Tokiwa H. FK phage for differentiating the classical and El T or groups of Vibrio cholerae. J Clin Microbiol. 1981 Aug;14(2):222–224. doi: 10.1128/jcm.14.2.222-224.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  354. Tamplin M. L., Carrillo Parodi C. Environmental spread of Vibrio cholerae in Peru. Lancet. 1991 Nov 9;338(8776):1216–1217. doi: 10.1016/0140-6736(91)92089-k. [DOI] [PubMed] [Google Scholar]
  355. Tamplin M. L., Colwell R. R., Hall S., Kogure K., Strichartz G. R. Sodium-channel inhibitors produced by enteropathogenic Vibrio cholerae and Aeromonas hydrophila. Lancet. 1987 Apr 25;1(8539):975–975. doi: 10.1016/s0140-6736(87)90317-5. [DOI] [PubMed] [Google Scholar]
  356. Tamplin M. L., Gauzens A. L., Huq A., Sack D. A., Colwell R. R. Attachment of Vibrio cholerae serogroup O1 to zooplankton and phytoplankton of Bangladesh waters. Appl Environ Microbiol. 1990 Jun;56(6):1977–1980. doi: 10.1128/aem.56.6.1977-1980.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  357. Tamura K., Shimada S., Prescott L. M. Vibrio agar: a new plating medium for isolation of Vibrio cholerae. Jpn J Med Sci Biol. 1971 Apr;24(2):125–127. doi: 10.7883/yoken1952.24.125. [DOI] [PubMed] [Google Scholar]
  358. Taylor J. L., Tuttle J., Pramukul T., O'Brien K., Barrett T. J., Jolbitado B., Lim Y. L., Vugia D., Morris J. G., Jr, Tauxe R. V. An outbreak of cholera in Maryland associated with imported commercial frozen fresh coconut milk. J Infect Dis. 1993 Jun;167(6):1330–1335. doi: 10.1093/infdis/167.6.1330. [DOI] [PubMed] [Google Scholar]
  359. Taylor R. K., Miller V. L., Furlong D. B., Mekalanos J. J. Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc Natl Acad Sci U S A. 1987 May;84(9):2833–2837. doi: 10.1073/pnas.84.9.2833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  360. Taylor R., Shaw C., Peterson K., Spears P., Mekalanos J. Safe, live Vibrio cholerae vaccines? Vaccine. 1988 Apr;6(2):151–154. doi: 10.1016/s0264-410x(88)80019-7. [DOI] [PubMed] [Google Scholar]
  361. Teppema J. S., Guinée P. A., Ibrahim A. A., Pâques M., Ruitenberg E. J. In vivo adherence and colonization of Vibrio cholerae strains that differ in hemagglutinating activity and motility. Infect Immun. 1987 Sep;55(9):2093–2102. doi: 10.1128/iai.55.9.2093-2102.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  362. Terai A., Baba K., Shirai H., Yoshida O., Takeda Y., Nishibuchi M. Evidence for insertion sequence-mediated spread of the thermostable direct hemolysin gene among Vibrio species. J Bacteriol. 1991 Aug;173(16):5036–5046. doi: 10.1128/jb.173.16.5036-5046.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  363. Towner K. J., Pearson N. J., Mhalu F. S., O'Grady F. Resistance to antimicrobial agents of Vibrio cholerae E1 Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania. Bull World Health Organ. 1980;58(5):747–751. [PMC free article] [PubMed] [Google Scholar]
  364. Trucksis M., Galen J. E., Michalski J., Fasano A., Kaper J. B. Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5267–5271. doi: 10.1073/pnas.90.11.5267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  365. Twedt R. M., Madden J. M., Hunt J. M., Francis D. W., Peeler J. T., Duran A. P., Hebert W. O., McCay S. G., Roderick C. N., Spite G. T. Characterization of Vibrio cholerae isolated from oysters. Appl Environ Microbiol. 1981 Jun;41(6):1475–1478. doi: 10.1128/aem.41.6.1475-1478.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  366. Varela P., Rivas M., Binsztein N., Cremona M. L., Herrmann P., Burrone O., Ugalde R. A., Frasch A. C. Identification of toxigenic Vibrio cholerae from the Argentine outbreak by PCR for ctx A1 and ctx A2-B. FEBS Lett. 1993 Jan 2;315(1):74–76. doi: 10.1016/0014-5793(93)81136-n. [DOI] [PubMed] [Google Scholar]
  367. Voss E., Attridge S. R. In vitro production of toxin-coregulated pili by Vibrio cholerae El Tor. Microb Pathog. 1993 Oct;15(4):255–268. doi: 10.1006/mpat.1993.1076. [DOI] [PubMed] [Google Scholar]
  368. WATTEN R. H., MORGAN F. M., YACHAI NA SONGKHLA, VANIKIATI B., PHILLIPS R. A. Water and electrolyte studies in cholera. J Clin Invest. 1959 Nov;38:1879–1889. doi: 10.1172/JCI103965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  369. Wachsmuth I. K., Evins G. M., Fields P. I., Olsvik O., Popovic T., Bopp C. A., Wells J. G., Carrillo C., Blake P. A. The molecular epidemiology of cholera in Latin America. J Infect Dis. 1993 Mar;167(3):621–626. doi: 10.1093/infdis/167.3.621. [DOI] [PubMed] [Google Scholar]
  370. Wang F., Butler T., Rabbani G. H., Jones P. K. The acidosis of cholera. Contributions of hyperproteinemia, lactic acidemia, and hyperphosphatemia to an increased serum anion gap. N Engl J Med. 1986 Dec 18;315(25):1591–1595. doi: 10.1056/NEJM198612183152506. [DOI] [PubMed] [Google Scholar]
  371. Wanke C. A., Guerrant R. L. Small-bowel colonization alone is a cause of diarrhea. Infect Immun. 1987 Aug;55(8):1924–1926. doi: 10.1128/iai.55.8.1924-1926.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  372. Winner L., 3rd, Mack J., Weltzin R., Mekalanos J. J., Kraehenbuhl J. P., Neutra M. R. New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect Immun. 1991 Mar;59(3):977–982. doi: 10.1128/iai.59.3.977-982.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  373. Woodward W. E. Cholera reinfection in man. J Infect Dis. 1971 Jan;123(1):61–66. doi: 10.1093/infdis/123.1.61. [DOI] [PubMed] [Google Scholar]
  374. Wright A. C., Guo Y., Johnson J. A., Nataro J. P., Morris J. G., Jr Development and testing of a nonradioactive DNA oligonucleotide probe that is specific for Vibrio cholerae cholera toxin. J Clin Microbiol. 1992 Sep;30(9):2302–2306. doi: 10.1128/jcm.30.9.2302-2306.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  375. Yam W. C., Lung M. L., Ng K. Y., Ng M. H. Molecular epidemiology of Vibrio cholerae in Hong Kong. J Clin Microbiol. 1989 Aug;27(8):1900–1902. doi: 10.1128/jcm.27.8.1900-1902.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  376. Yamamoto K., Ichinose Y., Nakasone N., Tanabe M., Nagahama M., Sakurai J., Iwanaga M. Identity of hemolysins produced by Vibrio cholerae non-O1 and V. cholerae O1, biotype El Tor. Infect Immun. 1986 Mar;51(3):927–931. doi: 10.1128/iai.51.3.927-931.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  377. Yamamoto K., Ichinose Y., Shinagawa H., Makino K., Nakata A., Iwanaga M., Honda T., Miwatani T. Two-step processing for activation of the cytolysin/hemolysin of Vibrio cholerae O1 biotype El Tor: nucleotide sequence of the structural gene (hlyA) and characterization of the processed products. Infect Immun. 1990 Dec;58(12):4106–4116. doi: 10.1128/iai.58.12.4106-4116.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  378. Yamamoto T., Kamano T., Uchimura M., Iwanaga M., Yokota T. Vibrio cholerae O1 adherence to villi and lymphoid follicle epithelium: in vitro model using formalin-treated human small intestine and correlation between adherence and cell-associated hemagglutinin levels. Infect Immun. 1988 Dec;56(12):3241–3250. doi: 10.1128/iai.56.12.3241-3250.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  379. Yamamoto T., Tamura T., Yokota T. Primary structure of heat-labile enterotoxin produced by Escherichia coli pathogenic for humans. J Biol Chem. 1984 Apr 25;259(8):5037–5044. [PubMed] [Google Scholar]
  380. Yamamoto T., Yokota T. Electron microscopic study of Vibrio cholerae O1 adherence to the mucus coat and villus surface in the human small intestine. Infect Immun. 1988 Oct;56(10):2753–2759. doi: 10.1128/iai.56.10.2753-2759.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  381. Yamamoto T., Yokota T. Sequence of heat-labile enterotoxin of Escherichia coli pathogenic for humans. J Bacteriol. 1983 Aug;155(2):728–733. doi: 10.1128/jb.155.2.728-733.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  382. Yamamoto T., Yokota T. Vibrio cholerae O1 adherence to human small intestinal M cells in vitro. J Infect Dis. 1989 Jul;160(1):168–169. doi: 10.1093/infdis/160.1.168. [DOI] [PubMed] [Google Scholar]
  383. Yancey R. J., Willis D. L., Berry L. J. Flagella-induced immunity against experimental cholera in adult rabbits. Infect Immun. 1979 Jul;25(1):220–228. doi: 10.1128/iai.25.1.220-228.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  384. Yoh M., Miyagi K., Matsumoto Y., Hayashi K., Takarada Y., Yamamoto K., Honda T. Development of an enzyme-labeled oligonucleotide probe for the cholera toxin gene. J Clin Microbiol. 1993 May;31(5):1312–1314. doi: 10.1128/jcm.31.5.1312-1314.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  385. Yu J., Webb H., Hirst T. R. A homologue of the Escherichia coli DsbA protein involved in disulphide bond formation is required for enterotoxin biogenesis in Vibrio cholerae. Mol Microbiol. 1992 Jul;6(14):1949–1958. doi: 10.1111/j.1365-2958.1992.tb01368.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES